Biobanking Market by Offering (Equipment & Accessories, Consumables, Software (On-Premise, Cloud), Services), by Function (Sample Collection, Sample Preparation, Sample Analysis and Data Management, Sample Storage, Sample Transportation, Others), by Application (Drug Discovery, Clinical Research, Life Science Research, Others), By Biological Sample Type (Blood Products, Human Waste, Cell Lines, Human Tissue, Others), by End Users (Biobanks, Pharma And Biotech Companies, Contract Research Organizations, Academic And Research Institutions, Others), by Distribution Channel (Online, Offline), By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2021 – 2029

Report ID :AMI-920 | Category : Healthcare | Published Date : September, 2021 | Pages : 402 | Format :PDF

Industry Trends

Biobanking market contributes to the advancement of biomedical and translational research by collecting and preserving biological samples such as blood, tissues, and nucleic acids, which are used in research to discover disease-relevant biomarkers, and further for diagnosis, prognosis, and drug response prediction. Increasing application areas of biobanking such as drug discovery, clinical research, life science research, and others are expected to be the major factors contributing towards the growth of global biobanking market over the forecast period. Moreover, increasing funding from private and government organizations for biobanking is boosting the market growth. Furthermore, companies operating in the global biobanking market are undertaing strategic initiatives, which is supplementing the market growth. For instance, Precision Medicine Group announced the purchase of ProMedDx and GLAS, two significant biospecimen providers, in August 2019. This acquisition will assist the company in expanding its biospecimen solution space as well as increasing scientific expertise and understanding.

The rise in chronic diseases such as cancer, autoimmune diseases, and blood disorders is fueling the biobanking market's expansion. Furthermore, increasing research and development programs in the Asia pacific Region is expected to further contribute to the market growth. However, in some developing countries biobanking investment are available in less manner, particularly in Africa, due to the high cost of installation and operation.

The covid-19 pandemic impacted the pharmaceutical and biotechnological industries worldwide. According to the World Health Organization (WHO), the covid-19 pandemic had infected nearly 2 million people by January 2021, resulting in enormous strain on the global biobanking market. When COVID-19 spread over the world, few hospitals and biobanks were adequately prepared for the influx of infected patients and high mortality rates associated with the virus. Biobanks had to communicate and search globally for the materials they required to gather and store specimens quickly. Biobanking solutions providers have witnessed enormous increase in demand amidst the pandemic since they enabled global researchers to access the source material and data needed to conduct clinical research and trials, regardless of the COVID-19 specimens' actual geographical location. Also, In the case of COVID-19, the Centers for Disease Control and Prevention (CDC) in the United States established recommendations for managing COVID-19 samples that served as a model for other biobanks. Furthermore, the increased promise of innovation in the biobanking services and equipment is estimated to showcase new opportunities for the growth of market participants in the biobanking market.

In terms of revenue, biobanking market was valued at US$ 2202.01 Mn in 2020 growing at a CAGR of 7.1% over the forecast period (2021 – 2029). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.

Global Biobanking Market Revenue & Forecast, (US$ Million), 2015 – 2029

Offering Outlook:

Based on offering, the global biobanking market has been segmented into equipment & accessories, consumables, software and services. The software segment is further bifurcated into on-premise and cloud. Software segment is expected to be the fastest growing segment over the coming years, owing to rapid digitization initiatives across end users along with growing adoption of cloud based technologies among enterprises. Furthermore, major companies in the market are also launching new products to gathered largest market share. Technidata Medical Software, for instance, offered a capability for its TDBioBank software package in September 2018. This software solution assists the biobank in increasing visibility and improving the quality of service given to their clients.

Function Outlook:

Based on function, the global biobanking market has been segmented into sample collection, sample preparation, sample analysis and data management, sample storage, sample transportation, and others. Among the segments, sample collection segment holds the largest market share in biobanking market in 2020. Increasing research and development across laboratories and institutes is predicted to increase the demand for biobanking equipment and consumables for sample collection. It is also used to gather biospecimens and biorepositories, as well as demographic data such as medical history, lifestyle habits, medications, and family history, in order to build an accurate scientific database.

Application Outlook:

Based on application, the global biobanking market has been segmented into drug discovery, clinical research, life science research, and others. Accelerating clinical and translational research for biomarker discovery through advanced, standardized cell isolation methodologies and rising automation in biobanking has contributed to the highest share of drug discovery segment in the global market in 2020.

Biological Sample Type Outlook:

On the basis of biological sample type, the global biobanking market has been classified into blood products, human waste, cell lines, human tissue, and others. The blood product segment accounted for the highest market share and is predicted to increase at the fastest rate throughout the forecast period. As a source of DNA and RNA, blood is the most common biospecimen in human biobanks. The majority of blood samples are collected at clinics, hospitals, and pathology collection centers. There is an increasing number of biobanks that assist to collect samples from the population as a response to the increased demand of sample collection and storage services, which is boosting the segment’s growth in the global market.

End Users Outlook:

Based on end users, the global biobanking market has been segmented into biobanks, pharma and biotech companies, contract research organizations, academic and research institutions, and others. Pharma and biotech companies is expected to witness fastest growth over the forecast period. Biobanking enables pharmaceutical and biotechnology businesses to gather, store, and analyze samples for testing and development of new medicines, diagnostics, and vaccines. The large scale research and development activities conducted by the pharma and biotech companies is estimated to contribute towards the segment’s growth in the global market over the period of next eight years.

Distribution Channel Outlook:

Based on distribution channel, the global biobanking market has been segmented into online and offline. Online mode of distribution channel is expected to be the fastest growing segment in the forecast years owing to increasing penetration of internet globally along with increasing adoption of online selling platforms in the pharmaceutical industry. Bionanking market participants are increasingly relying on online sales channel to cater to a lager consumer base, globally.

Region Outlook:

North America accounted for the largest share in the global biobanking market in 2020 and is likely to maintain its dominance during the forecast period, owing to increased adoption of advanced technologies and increased investments towards biobanking solutions among healthcare professionals and those working in the R&D industry. Furthermore, the biobanking market in North America is expected to rise due to increase in R&D activities in the healthcare sector to develop novel biobanking, as well as the presence of significant companies in the region.

Competitive Landscape Outlook:

The report provides both, qualitative and quantitative research of biobanking market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analyzed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.

Some of the players operating in the biobanking market are Agilent Technologies, Inc., Becton, Dickinson and Company, Brooks Life Sciences, CloudLIMS.com, Cryo Bio System, Hamilton Company, LabVantage Solutions Inc., LabWare, LiCONiC AG, PHC Corporation, QIAGEN, Thermo Fisher Scientific Inc., and other market participants.

Click on image to enlarge

Global Biobanking Market:

By Offering

Equipment & Accessories
Consumables
Software
- On-Premise
- Cloud
Services

By Function

Sample Collection
Sample Preparation
Sample Analysis and Data Management
Sample Storage
Sample Transportation
Others

By Application

Drug Discovery
Clinical Research
Life Science Research
Others

By Biological Sample Type

Blood Products
Human Waste
Cell Lines
Human Tissue
Others

By End Users

Biobanks
Pharma and Biotech Companies
Contract Research Organizations
Academic and Research Institutions
Others

By Distribution Channel

Online
Offline

By Region

Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
  - Denmark
  - Finland
  - Iceland
  - Sweden
  - Norway
- Benelux Union
  - Belgium
  - The Netherlands
  - Luxembourg
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
  - Indonesia
  - Thailand
  - Malaysia
  - Singapore
  - Rest of Southeast Asia
- Rest of Asia Pacific
Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America

North America
- U.S.
- Canada
- Mexico
- Rest of North America

Table of Contents

1. Market Scope

1.1. Market Segmentation

1.2. Years Considered

1.2.1. Historic Years: 2015 - 2019

1.2.2. Base Year: 2020

1.2.3. Forecast Years: 2021 – 2029

2. Key Target Audiences

3. Research Methodology

3.1. Primary Research

3.1.1. Research Questionnaire

3.1.2. Global Percentage Breakdown

3.1.3. Primary Interviews: Key Opinion Leaders (KOLs)

3.2. Secondary Research

3.2.1. Paid Databases

3.2.2. Secondary Sources

3.3. Market Size Estimates

3.3.1. Top-Down Approach

3.3.2. Bottom-Up Approach

3.4. Data Triangulation Methodology

3.5. Research Assumptions

4. Recommendations and Insights from AMI’s Perspective**

5. Holistic Overview of Biobanking Market

6. Market Synopsis: Biobanking Market

7. Biobanking Market Analysis: Qualitative Perspective

7.1. Introduction

7.1.1. Product Definition

7.1.2. Industry Development

7.2. Market Dynamics

7.2.1. Drivers

7.2.2. Restraints

7.2.3. Opportunities

7.3. Trends in Biobanking Market

7.4. Market Determinants Radar Chart

7.5. Macro-Economic and Micro-Economic Indicators: Biobanking Market

7.6. Porter’s Five Force Analysis

7.7. Impact of Covid-19 on Biobanking Market

8. Global Biobanking Market Analysis and Forecasts, 2021 – 2029

8.1. Overview

8.1.1. Global Biobanking Market Revenue (US$ Mn)

8.2. Global Biobanking Market Revenue (US$ Mn) and Forecasts, By Offering

8.2.1. Equipment and Accessories

8.2.1.1. Definition

8.2.1.2. Market Estimation and Penetration, 2015 - 2020

8.2.1.3. Market Forecast, 2021 - 2029

8.2.1.4. Compound Annual Growth Rate (CAGR)

8.2.1.5. Regional Bifurcation

8.2.1.5.1. North America

8.2.1.5.1.1. Market Estimation, 2015 - 2020

8.2.1.5.1.2. Market Forecast, 2021 - 2029

8.2.1.5.2. Europe

8.2.1.5.2.1. Market Estimation, 2015 - 2020

8.2.1.5.2.2. Market Forecast, 2021 - 2029

8.2.1.5.3. Asia Pacific

8.2.1.5.3.1. Market Estimation, 2015 - 2020

8.2.1.5.3.2. Market Forecast, 2021 - 2029

8.2.1.5.4. Middle East and Africa

8.2.1.5.4.1. Market Estimation, 2015 - 2020

8.2.1.5.4.2. Market Forecast, 2021 - 2029

8.2.1.5.5. Latin America

8.2.1.5.5.1. Market Estimation, 2015 - 2020

8.2.1.5.5.2. Market Forecast, 2021 - 2029

8.2.2. Consumables

8.2.2.1. Definition

8.2.2.2. Market Estimation and Penetration, 2015 - 2020

8.2.2.3. Market Forecast, 2021 - 2029

8.2.2.4. Compound Annual Growth Rate (CAGR)

8.2.2.5. Regional Bifurcation

8.2.2.5.1. North America

8.2.2.5.1.1. Market Estimation, 2015 - 2020

8.2.2.5.1.2. Market Forecast, 2021 - 2029

8.2.2.5.2. Europe

8.2.2.5.2.1. Market Estimation, 2015 - 2020

8.2.2.5.2.2. Market Forecast, 2021 - 2029

8.2.2.5.3. Asia Pacific

8.2.2.5.3.1. Market Estimation, 2015 - 2020

8.2.2.5.3.2. Market Forecast, 2021 - 2029

8.2.2.5.4. Middle East and Africa

8.2.2.5.4.1. Market Estimation, 2015 - 2020

8.2.2.5.4.2. Market Forecast, 2021 - 2029

8.2.2.5.5. Latin America

8.2.2.5.5.1. Market Estimation, 2015 - 2020

8.2.2.5.5.2. Market Forecast, 2021 - 2029

8.2.3. Software (Definition, Market Estimation and Penetration, 2015 - 2020, Market Estimation (2015 - 2020), Market Forecast (2021 - 2029), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on On-Premise, Cloud)

8.2.3.1. On-Premise

8.2.3.2. Cloud

8.2.4. Services

8.2.4.1. Definition

8.2.4.2. Market Estimation and Penetration, 2015 - 2020

8.2.4.3. Market Forecast, 2021 - 2029

8.2.4.4. Compound Annual Growth Rate (CAGR)

8.2.4.5. Regional Bifurcation

8.2.4.5.1. North America

8.2.4.5.1.1. Market Estimation, 2015 - 2020

8.2.4.5.1.2. Market Forecast, 2021 - 2029

8.2.4.5.2. Europe

8.2.4.5.2.1. Market Estimation, 2015 - 2020

8.2.4.5.2.2. Market Forecast, 2021 - 2029

8.2.4.5.3. Asia Pacific

8.2.4.5.3.1. Market Estimation, 2015 - 2020

8.2.4.5.3.2. Market Forecast, 2021 - 2029

8.2.4.5.4. Middle East and Africa

8.2.4.5.4.1. Market Estimation, 2015 - 2020

8.2.4.5.4.2. Market Forecast, 2021 - 2029

8.2.4.5.5. Latin America

8.2.4.5.5.1. Market Estimation, 2015 - 2020

8.2.4.5.5.2. Market Forecast, 2021 - 2029

8.3. Key Segment for Channeling Investments

8.3.1. By Offering

9. Global Biobanking Market Analysis and Forecasts, 2021 – 2029

9.1. Overview

9.2. Global Biobanking Market Revenue (US$ Mn) and Forecasts, By Function

9.2.1. Sample Collection

9.2.1.1. Definition

9.2.1.2. Market Estimation and Penetration, 2015 - 2020

9.2.1.3. Market Forecast, 2021 - 2029

9.2.1.4. Compound Annual Growth Rate (CAGR)

9.2.1.5. Regional Bifurcation

9.2.1.5.1. North America

9.2.1.5.1.1. Market Estimation, 2015 - 2020

9.2.1.5.1.2. Market Forecast, 2021 - 2029

9.2.1.5.2. Europe

9.2.1.5.2.1. Market Estimation, 2015 - 2020

9.2.1.5.2.2. Market Forecast, 2021 - 2029

9.2.1.5.3. Asia Pacific

9.2.1.5.3.1. Market Estimation, 2015 - 2020

9.2.1.5.3.2. Market Forecast, 2021 - 2029

9.2.1.5.4. Middle East and Africa

9.2.1.5.4.1. Market Estimation, 2015 - 2020

9.2.1.5.4.2. Market Forecast, 2021 - 2029

9.2.1.5.5. Latin America

9.2.1.5.5.1. Market Estimation, 2015 - 2020

9.2.1.5.5.2. Market Forecast, 2021 - 2029

9.2.2. Sample Preparation

9.2.2.1. Definition

9.2.2.2. Market Estimation and Penetration, 2015 - 2020

9.2.2.3. Market Forecast, 2021 - 2029

9.2.2.4. Compound Annual Growth Rate (CAGR)

9.2.2.5. Regional Bifurcation

9.2.2.5.1. North America

9.2.2.5.1.1. Market Estimation, 2015 - 2020

9.2.2.5.1.2. Market Forecast, 2021 - 2029

9.2.2.5.2. Europe

9.2.2.5.2.1. Market Estimation, 2015 - 2020

9.2.2.5.2.2. Market Forecast, 2021 - 2029

9.2.2.5.3. Asia Pacific

9.2.2.5.3.1. Market Estimation, 2015 - 2020

9.2.2.5.3.2. Market Forecast, 2021 - 2029

9.2.2.5.4. Middle East and Africa

9.2.2.5.4.1. Market Estimation, 2015 - 2020

9.2.2.5.4.2. Market Forecast, 2021 - 2029

9.2.2.5.5. Latin America

9.2.2.5.5.1. Market Estimation, 2015 - 2020

9.2.2.5.5.2. Market Forecast, 2021 - 2029

9.2.3. Sample Analysis and Data Management

9.2.3.1. Definition

9.2.3.2. Market Estimation and Penetration, 2015 - 2020

9.2.3.3. Market Forecast, 2021 - 2029

9.2.3.4. Compound Annual Growth Rate (CAGR)

9.2.3.5. Regional Bifurcation

9.2.3.5.1. North America

9.2.3.5.1.1. Market Estimation, 2015 - 2020

9.2.3.5.1.2. Market Forecast, 2021 - 2029

9.2.3.5.2. Europe

9.2.3.5.2.1. Market Estimation, 2015 - 2020

9.2.3.5.2.2. Market Forecast, 2021 - 2029

9.2.3.5.3. Asia Pacific

9.2.3.5.3.1. Market Estimation, 2015 - 2020

9.2.3.5.3.2. Market Forecast, 2021 - 2029

9.2.3.5.4. Middle East and Africa

9.2.3.5.4.1. Market Estimation, 2015 - 2020

9.2.3.5.4.2. Market Forecast, 2021 - 2029

9.2.3.5.5. Latin America

9.2.3.5.5.1. Market Estimation, 2015 - 2020

9.2.3.5.5.2. Market Forecast, 2021 - 2029

9.2.4. Sample Storage

9.2.4.1. Definition

9.2.4.2. Market Estimation and Penetration, 2015 - 2020

9.2.4.3. Market Forecast, 2021 - 2029

9.2.4.4. Compound Annual Growth Rate (CAGR)

9.2.4.5. Regional Bifurcation

9.2.4.5.1. North America

9.2.4.5.1.1. Market Estimation, 2015 - 2020

9.2.4.5.1.2. Market Forecast, 2021 - 2029

9.2.4.5.2. Europe

9.2.4.5.2.1. Market Estimation, 2015 - 2020

9.2.4.5.2.2. Market Forecast, 2021 - 2029

9.2.4.5.3. Asia Pacific

9.2.4.5.3.1. Market Estimation, 2015 - 2020

9.2.4.5.3.2. Market Forecast, 2021 - 2029

9.2.4.5.4. Middle East and Africa

9.2.4.5.4.1. Market Estimation, 2015 - 2020

9.2.4.5.4.2. Market Forecast, 2021 - 2029

9.2.4.5.5. Latin America

9.2.4.5.5.1. Market Estimation, 2015 - 2020

9.2.4.5.5.2. Market Forecast, 2021 - 2029

9.2.5. Sample Transportation

9.2.5.1. Definition

9.2.5.2. Market Estimation and Penetration, 2015 - 2020

9.2.5.3. Market Forecast, 2021 - 2029

9.2.5.4. Compound Annual Growth Rate (CAGR)

9.2.5.5. Regional Bifurcation

9.2.5.5.1. North America

9.2.5.5.1.1. Market Estimation, 2015 - 2020

9.2.5.5.1.2. Market Forecast, 2021 - 2029

9.2.5.5.2. Europe

9.2.5.5.2.1. Market Estimation, 2015 - 2020

9.2.5.5.2.2. Market Forecast, 2021 - 2029

9.2.5.5.3. Asia Pacific

9.2.5.5.3.1. Market Estimation, 2015 - 2020

9.2.5.5.3.2. Market Forecast, 2021 - 2029

9.2.5.5.4. Middle East and Africa

9.2.5.5.4.1. Market Estimation, 2015 - 2020

9.2.5.5.4.2. Market Forecast, 2021 - 2029

9.2.5.5.5. Latin America

9.2.5.5.5.1. Market Estimation, 2015 - 2020

9.2.5.5.5.2. Market Forecast, 2021 - 2029

9.2.6. Others

9.2.6.1. Definition

9.2.6.2. Market Estimation and Penetration, 2015 - 2020

9.2.6.3. Market Forecast, 2021 - 2029

9.2.6.4. Compound Annual Growth Rate (CAGR)

9.2.6.5. Regional Bifurcation

9.2.6.5.1. North America

9.2.6.5.1.1. Market Estimation, 2015 - 2020

9.2.6.5.1.2. Market Forecast, 2021 - 2029

9.2.6.5.2. Europe

9.2.6.5.2.1. Market Estimation, 2015 - 2020

9.2.6.5.2.2. Market Forecast, 2021 - 2029

9.2.6.5.3. Asia Pacific

9.2.6.5.3.1. Market Estimation, 2015 - 2020

9.2.6.5.3.2. Market Forecast, 2021 - 2029

9.2.6.5.4. Middle East and Africa

9.2.6.5.4.1. Market Estimation, 2015 - 2020

9.2.6.5.4.2. Market Forecast, 2021 - 2029

9.2.6.5.5. Latin America

9.2.6.5.5.1. Market Estimation, 2015 - 2020

9.2.6.5.5.2. Market Forecast, 2021 - 2029

9.3. Key Segment for Channeling Investments

9.3.1. By Function

10. Global Biobanking Market Analysis and Forecasts, 2021 – 2029

10.1. Overview

10.2. Global Biobanking Market Revenue (US$ Mn) and Forecasts, By Application

10.2.1. Drug Discovery

10.2.1.1. Definition

10.2.1.2. Market Estimation and Penetration, 2015 - 2020

10.2.1.3. Market Forecast, 2021 - 2029

10.2.1.4. Compound Annual Growth Rate (CAGR)

10.2.1.5. Regional Bifurcation

10.2.1.5.1. North America

10.2.1.5.1.1. Market Estimation, 2015 - 2020

10.2.1.5.1.2. Market Forecast, 2021 - 2029

10.2.1.5.2. Europe

10.2.1.5.2.1. Market Estimation, 2015 - 2020

10.2.1.5.2.2. Market Forecast, 2021 - 2029

10.2.1.5.3. Asia Pacific

10.2.1.5.3.1. Market Estimation, 2015 - 2020

10.2.1.5.3.2. Market Forecast, 2021 - 2029

10.2.1.5.4. Middle East and Africa

10.2.1.5.4.1. Market Estimation, 2015 - 2020

10.2.1.5.4.2. Market Forecast, 2021 - 2029

10.2.1.5.5. Latin America

10.2.1.5.5.1. Market Estimation, 2015 - 2020

10.2.1.5.5.2. Market Forecast, 2021 - 2029

10.2.2. Clinical Research

10.2.2.1. Definition

10.2.2.2. Market Estimation and Penetration, 2015 - 2020

10.2.2.3. Market Forecast, 2021 - 2029

10.2.2.4. Compound Annual Growth Rate (CAGR)

10.2.2.5. Regional Bifurcation

10.2.2.5.1. North America

10.2.2.5.1.1. Market Estimation, 2015 - 2020

10.2.2.5.1.2. Market Forecast, 2021 - 2029

10.2.2.5.2. Europe

10.2.2.5.2.1. Market Estimation, 2015 - 2020

10.2.2.5.2.2. Market Forecast, 2021 - 2029

10.2.2.5.3. Asia Pacific

10.2.2.5.3.1. Market Estimation, 2015 - 2020

10.2.2.5.3.2. Market Forecast, 2021 - 2029

10.2.2.5.4. Middle East and Africa

10.2.2.5.4.1. Market Estimation, 2015 - 2020

10.2.2.5.4.2. Market Forecast, 2021 - 2029

10.2.2.5.5. Latin America

10.2.2.5.5.1. Market Estimation, 2015 - 2020

10.2.2.5.5.2. Market Forecast, 2021 - 2029

10.2.3. Life Science Research

10.2.3.1. Definition

10.2.3.2. Market Estimation and Penetration, 2015 - 2020

10.2.3.3. Market Forecast, 2021 - 2029

10.2.3.4. Compound Annual Growth Rate (CAGR)

10.2.3.5. Regional Bifurcation

10.2.3.5.1. North America

10.2.3.5.1.1. Market Estimation, 2015 - 2020

10.2.3.5.1.2. Market Forecast, 2021 - 2029

10.2.3.5.2. Europe

10.2.3.5.2.1. Market Estimation, 2015 - 2020

10.2.3.5.2.2. Market Forecast, 2021 - 2029

10.2.3.5.3. Asia Pacific

10.2.3.5.3.1. Market Estimation, 2015 - 2020

10.2.3.5.3.2. Market Forecast, 2021 - 2029

10.2.3.5.4. Middle East and Africa

10.2.3.5.4.1. Market Estimation, 2015 - 2020

10.2.3.5.4.2. Market Forecast, 2021 - 2029

10.2.3.5.5. Latin America

10.2.3.5.5.1. Market Estimation, 2015 - 2020

10.2.3.5.5.2. Market Forecast, 2021 - 2029

10.2.4. Others

10.2.4.1. Definition

10.2.4.2. Market Estimation and Penetration, 2015 - 2020

10.2.4.3. Market Forecast, 2021 - 2029

10.2.4.4. Compound Annual Growth Rate (CAGR)

10.2.4.5. Regional Bifurcation

10.2.4.5.1. North America

10.2.4.5.1.1. Market Estimation, 2015 - 2020

10.2.4.5.1.2. Market Forecast, 2021 - 2029

10.2.4.5.2. Europe

10.2.4.5.2.1. Market Estimation, 2015 - 2020

10.2.4.5.2.2. Market Forecast, 2021 - 2029

10.2.4.5.3. Asia Pacific

10.2.4.5.3.1. Market Estimation, 2015 - 2020

10.2.4.5.3.2. Market Forecast, 2021 - 2029

10.2.4.5.4. Middle East and Africa

10.2.4.5.4.1. Market Estimation, 2015 - 2020

10.2.4.5.4.2. Market Forecast, 2021 - 2029

10.2.4.5.5. Latin America

10.2.4.5.5.1. Market Estimation, 2015 - 2020

10.2.4.5.5.2. Market Forecast, 2021 - 2029

10.3. Key Segment for Channeling Investments

10.3.1. By Application

11. Global Biobanking Market Analysis and Forecasts, 2021 – 2029

11.1. Overview

11.2. Global Biobanking Market Revenue (US$ Mn) and Forecasts, By Biological Sample Type

11.2.1. Blood Products

11.2.1.1. Definition

11.2.1.2. Market Estimation and Penetration, 2015 - 2020

11.2.1.3. Market Forecast, 2021 - 2029

11.2.1.4. Compound Annual Growth Rate (CAGR)

11.2.1.5. Regional Bifurcation

11.2.1.5.1. North America

11.2.1.5.1.1. Market Estimation, 2015 - 2020

11.2.1.5.1.2. Market Forecast, 2021 - 2029

11.2.1.5.2. Europe

11.2.1.5.2.1. Market Estimation, 2015 - 2020

11.2.1.5.2.2. Market Forecast, 2021 - 2029

11.2.1.5.3. Asia Pacific

11.2.1.5.3.1. Market Estimation, 2015 - 2020

11.2.1.5.3.2. Market Forecast, 2021 - 2029

11.2.1.5.4. Middle East and Africa

11.2.1.5.4.1. Market Estimation, 2015 - 2020

11.2.1.5.4.2. Market Forecast, 2021 - 2029

11.2.1.5.5. Latin America

11.2.1.5.5.1. Market Estimation, 2015 - 2020

11.2.1.5.5.2. Market Forecast, 2021 - 2029

11.2.2. Human Waste

11.2.2.1. Definition

11.2.2.2. Market Estimation and Penetration, 2015 - 2020

11.2.2.3. Market Forecast, 2021 - 2029

11.2.2.4. Compound Annual Growth Rate (CAGR)

11.2.2.5. Regional Bifurcation

11.2.2.5.1. North America

11.2.2.5.1.1. Market Estimation, 2015 - 2020

11.2.2.5.1.2. Market Forecast, 2021 - 2029

11.2.2.5.2. Europe

11.2.2.5.2.1. Market Estimation, 2015 - 2020

11.2.2.5.2.2. Market Forecast, 2021 - 2029

11.2.2.5.3. Asia Pacific

11.2.2.5.3.1. Market Estimation, 2015 - 2020

11.2.2.5.3.2. Market Forecast, 2021 - 2029

11.2.2.5.4. Middle East and Africa

11.2.2.5.4.1. Market Estimation, 2015 - 2020

11.2.2.5.4.2. Market Forecast, 2021 - 2029

11.2.2.5.5. Latin America

11.2.2.5.5.1. Market Estimation, 2015 - 2020

11.2.2.5.5.2. Market Forecast, 2021 - 2029

11.2.3. Cell Lines

11.2.3.1. Definition

11.2.3.2. Market Estimation and Penetration, 2015 - 2020

11.2.3.3. Market Forecast, 2021 - 2029

11.2.3.4. Compound Annual Growth Rate (CAGR)

11.2.3.5. Regional Bifurcation

11.2.3.5.1. North America

11.2.3.5.1.1. Market Estimation, 2015 - 2020

11.2.3.5.1.2. Market Forecast, 2021 - 2029

11.2.3.5.2. Europe

11.2.3.5.2.1. Market Estimation, 2015 - 2020

11.2.3.5.2.2. Market Forecast, 2021 - 2029

11.2.3.5.3. Asia Pacific

11.2.3.5.3.1. Market Estimation, 2015 - 2020

11.2.3.5.3.2. Market Forecast, 2021 - 2029

11.2.3.5.4. Middle East and Africa

11.2.3.5.4.1. Market Estimation, 2015 - 2020

11.2.3.5.4.2. Market Forecast, 2021 - 2029

11.2.3.5.5. Latin America

11.2.3.5.5.1. Market Estimation, 2015 - 2020

11.2.3.5.5.2. Market Forecast, 2021 - 2029

11.2.4. Human Tissue

11.2.4.1. Definition

11.2.4.2. Market Estimation and Penetration, 2015 - 2020

11.2.4.3. Market Forecast, 2021 - 2029

11.2.4.4. Compound Annual Growth Rate (CAGR)

11.2.4.5. Regional Bifurcation

11.2.4.5.1. North America

11.2.4.5.1.1. Market Estimation, 2015 - 2020

11.2.4.5.1.2. Market Forecast, 2021 - 2029

11.2.4.5.2. Europe

11.2.4.5.2.1. Market Estimation, 2015 - 2020

11.2.4.5.2.2. Market Forecast, 2021 - 2029

11.2.4.5.3. Asia Pacific

11.2.4.5.3.1. Market Estimation, 2015 - 2020

11.2.4.5.3.2. Market Forecast, 2021 - 2029

11.2.4.5.4. Middle East and Africa

11.2.4.5.4.1. Market Estimation, 2015 - 2020

11.2.4.5.4.2. Market Forecast, 2021 - 2029

11.2.4.5.5. Latin America

11.2.4.5.5.1. Market Estimation, 2015 - 2020

11.2.4.5.5.2. Market Forecast, 2021 - 2029

11.2.5. Others

11.2.5.1. Definition

11.2.5.2. Market Estimation and Penetration, 2015 - 2020

11.2.5.3. Market Forecast, 2021 - 2029

11.2.5.4. Compound Annual Growth Rate (CAGR)

11.2.5.5. Regional Bifurcation

11.2.5.5.1. North America

11.2.5.5.1.1. Market Estimation, 2015 - 2020

11.2.5.5.1.2. Market Forecast, 2021 - 2029

11.2.5.5.2. Europe

11.2.5.5.2.1. Market Estimation, 2015 - 2020

11.2.5.5.2.2. Market Forecast, 2021 - 2029

11.2.5.5.3. Asia Pacific

11.2.5.5.3.1. Market Estimation, 2015 - 2020

11.2.5.5.3.2. Market Forecast, 2021 - 2029

11.2.5.5.4. Middle East and Africa

11.2.5.5.4.1. Market Estimation, 2015 - 2020

11.2.5.5.4.2. Market Forecast, 2021 - 2029

11.2.5.5.5. Latin America

11.2.5.5.5.1. Market Estimation, 2015 - 2020

11.2.5.5.5.2. Market Forecast, 2021 - 2029

11.3. Key Segment for Channeling Investments

11.3.1. By Biological Sample Type

12. Global Biobanking Market Analysis and Forecasts, 2021 – 2029

12.1. Overview

12.2. Global Biobanking Market Revenue (US$ Mn) and Forecasts, By End Users

12.2.1. Biobanks

12.2.1.1. Definition

12.2.1.2. Market Estimation and Penetration, 2015 - 2020

12.2.1.3. Market Forecast, 2021 - 2029

12.2.1.4. Compound Annual Growth Rate (CAGR)

12.2.1.5. Regional Bifurcation

12.2.1.5.1. North America

12.2.1.5.1.1. Market Estimation, 2015 - 2020

12.2.1.5.1.2. Market Forecast, 2021 - 2029

12.2.1.5.2. Europe

12.2.1.5.2.1. Market Estimation, 2015 - 2020

12.2.1.5.2.2. Market Forecast, 2021 - 2029

12.2.1.5.3. Asia Pacific

12.2.1.5.3.1. Market Estimation, 2015 - 2020

12.2.1.5.3.2. Market Forecast, 2021 - 2029

12.2.1.5.4. Middle East and Africa

12.2.1.5.4.1. Market Estimation, 2015 - 2020

12.2.1.5.4.2. Market Forecast, 2021 - 2029

12.2.1.5.5. Latin America

12.2.1.5.5.1. Market Estimation, 2015 - 2020

12.2.1.5.5.2. Market Forecast, 2021 - 2029

12.2.2. Pharma and Biotech Companies

12.2.2.1. Definition

12.2.2.2. Market Estimation and Penetration, 2015 - 2020

12.2.2.3. Market Forecast, 2021 - 2029

12.2.2.4. Compound Annual Growth Rate (CAGR)

12.2.2.5. Regional Bifurcation

12.2.2.5.1. North America

12.2.2.5.1.1. Market Estimation, 2015 - 2020

12.2.2.5.1.2. Market Forecast, 2021 - 2029

12.2.2.5.2. Europe

12.2.2.5.2.1. Market Estimation, 2015 - 2020

12.2.2.5.2.2. Market Forecast, 2021 - 2029

12.2.2.5.3. Asia Pacific

12.2.2.5.3.1. Market Estimation, 2015 - 2020

12.2.2.5.3.2. Market Forecast, 2021 - 2029

12.2.2.5.4. Middle East and Africa

12.2.2.5.4.1. Market Estimation, 2015 - 2020

12.2.2.5.4.2. Market Forecast, 2021 - 2029

12.2.2.5.5. Latin America

12.2.2.5.5.1. Market Estimation, 2015 - 2020

12.2.2.5.5.2. Market Forecast, 2021 - 2029

12.2.3. Contract Research Organizations

12.2.3.1. Definition

12.2.3.2. Market Estimation and Penetration, 2015 - 2020

12.2.3.3. Market Forecast, 2021 - 2029

12.2.3.4. Compound Annual Growth Rate (CAGR)

12.2.3.5. Regional Bifurcation

12.2.3.5.1. North America

12.2.3.5.1.1. Market Estimation, 2015 - 2020

12.2.3.5.1.2. Market Forecast, 2021 - 2029

12.2.3.5.2. Europe

12.2.3.5.2.1. Market Estimation, 2015 - 2020

12.2.3.5.2.2. Market Forecast, 2021 - 2029

12.2.3.5.3. Asia Pacific

12.2.3.5.3.1. Market Estimation, 2015 - 2020

12.2.3.5.3.2. Market Forecast, 2021 - 2029

12.2.3.5.4. Middle East and Africa

12.2.3.5.4.1. Market Estimation, 2015 - 2020

12.2.3.5.4.2. Market Forecast, 2021 - 2029

12.2.3.5.5. Latin America

12.2.3.5.5.1. Market Estimation, 2015 - 2020

12.2.3.5.5.2. Market Forecast, 2021 - 2029

12.2.4. Academic and Research Institutions

12.2.4.1. Definition

12.2.4.2. Market Estimation and Penetration, 2015 - 2020

12.2.4.3. Market Forecast, 2021 - 2029

12.2.4.4. Compound Annual Growth Rate (CAGR)

12.2.4.5. Regional Bifurcation

12.2.4.5.1. North America

12.2.4.5.1.1. Market Estimation, 2015 - 2020

12.2.4.5.1.2. Market Forecast, 2021 - 2029

12.2.4.5.2. Europe

12.2.4.5.2.1. Market Estimation, 2015 - 2020

12.2.4.5.2.2. Market Forecast, 2021 - 2029

12.2.4.5.3. Asia Pacific

12.2.4.5.3.1. Market Estimation, 2015 - 2020

12.2.4.5.3.2. Market Forecast, 2021 - 2029

12.2.4.5.4. Middle East and Africa

12.2.4.5.4.1. Market Estimation, 2015 - 2020

12.2.4.5.4.2. Market Forecast, 2021 - 2029

12.2.4.5.5. Latin America

12.2.4.5.5.1. Market Estimation, 2015 - 2020

12.2.4.5.5.2. Market Forecast, 2021 - 2029

12.2.5. Others

12.2.5.1. Definition

12.2.5.2. Market Estimation and Penetration, 2015 - 2020

12.2.5.3. Market Forecast, 2021 - 2029

12.2.5.4. Compound Annual Growth Rate (CAGR)

12.2.5.5. Regional Bifurcation

12.2.5.5.1. North America

12.2.5.5.1.1. Market Estimation, 2015 - 2020

12.2.5.5.1.2. Market Forecast, 2021 - 2029

12.2.5.5.2. Europe

12.2.5.5.2.1. Market Estimation, 2015 - 2020

12.2.5.5.2.2. Market Forecast, 2021 - 2029

12.2.5.5.3. Asia Pacific

12.2.5.5.3.1. Market Estimation, 2015 - 2020

12.2.5.5.3.2. Market Forecast, 2021 - 2029

12.2.5.5.4. Middle East and Africa

12.2.5.5.4.1. Market Estimation, 2015 - 2020

12.2.5.5.4.2. Market Forecast, 2021 - 2029

12.2.5.5.5. Latin America

12.2.5.5.5.1. Market Estimation, 2015 - 2020

12.2.5.5.5.2. Market Forecast, 2021 - 2029

12.3. Key Segment for Channeling Investments

12.3.1. By End Users

13. Global Biobanking Market Analysis and Forecasts, 2021 – 2029

13.1. Overview

13.2. Global Biobanking Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

13.2.1. Online

13.2.1.1. Definition

13.2.1.2. Market Estimation and Penetration, 2015 - 2020

13.2.1.3. Market Forecast, 2021 - 2029

13.2.1.4. Compound Annual Growth Rate (CAGR)

13.2.1.5. Regional Bifurcation

13.2.1.5.1. North America

13.2.1.5.1.1. Market Estimation, 2015 - 2020

13.2.1.5.1.2. Market Forecast, 2021 - 2029

13.2.1.5.2. Europe

13.2.1.5.2.1. Market Estimation, 2015 - 2020

13.2.1.5.2.2. Market Forecast, 2021 - 2029

13.2.1.5.3. Asia Pacific

13.2.1.5.3.1. Market Estimation, 2015 - 2020

13.2.1.5.3.2. Market Forecast, 2021 - 2029

13.2.1.5.4. Middle East and Africa

13.2.1.5.4.1. Market Estimation, 2015 - 2020

13.2.1.5.4.2. Market Forecast, 2021 - 2029

13.2.1.5.5. Latin America

13.2.1.5.5.1. Market Estimation, 2015 - 2020

13.2.1.5.5.2. Market Forecast, 2021 - 2029

13.2.2. Offline

13.2.2.1. Definition

13.2.2.2. Market Estimation and Penetration, 2015 - 2020

13.2.2.3. Market Forecast, 2021 - 2029

13.2.2.4. Compound Annual Growth Rate (CAGR)

13.2.2.5. Regional Bifurcation

13.2.2.5.1. North America

13.2.2.5.1.1. Market Estimation, 2015 - 2020

13.2.2.5.1.2. Market Forecast, 2021 - 2029

13.2.2.5.2. Europe

13.2.2.5.2.1. Market Estimation, 2015 - 2020

13.2.2.5.2.2. Market Forecast, 2021 - 2029

13.2.2.5.3. Asia Pacific

13.2.2.5.3.1. Market Estimation, 2015 - 2020

13.2.2.5.3.2. Market Forecast, 2021 - 2029

13.2.2.5.4. Middle East and Africa

13.2.2.5.4.1. Market Estimation, 2015 - 2020

13.2.2.5.4.2. Market Forecast, 2021 - 2029

13.2.2.5.5. Latin America

13.2.2.5.5.1. Market Estimation, 2015 - 2020

13.2.2.5.5.2. Market Forecast, 2021 - 2029

13.3. Key Segment for Channeling Investments

13.3.1. By Distribution Channel

14. North America Biobanking Market Analysis and Forecasts, 2021 - 2029

14.1. Overview

14.1.1. North America Biobanking Market Revenue (US$ Mn)

14.2. North America Biobanking Market Revenue (US$ Mn) and Forecasts, By Offering

14.2.1. Equipment and Accessories

14.2.2. Consumables

14.2.3. Software

14.2.3.1. On-Premise

14.2.3.2. Cloud

14.2.4. Services

14.3. North America Biobanking Market Revenue (US$ Mn) and Forecasts, By Function

14.3.1. Sample Collection

14.3.2. Sample Preparation

14.3.3. Sample Analysis and Data Management

14.3.4. Sample Storage

14.3.5. Sample Transportation

14.3.6. Others

14.4. North America Biobanking Market Revenue (US$ Mn) and Forecasts, By Application

14.4.1. Drug Discovery

14.4.2. Clinical Research

14.4.3. Life Science Research

14.4.4. Others

14.5. North America Biobanking Market Revenue (US$ Mn) and Forecasts, By Biological Sample Type

14.5.1. Blood Products

14.5.2. Human Waste

14.5.3. Cell Lines

14.5.4. Human Tissue

14.5.5. Others

14.6. North America Biobanking Market Revenue (US$ Mn) and Forecasts, By End Users

14.6.1. Biobanks

14.6.2. Pharma and Biotech Companies

14.6.3. Contract Research Organizations

14.6.4. Academic and Research Institutions

14.6.5. Others

14.7. North America Biobanking Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

14.7.1. Online

14.7.2. Offline

14.8. North America Biobanking Market Revenue (US$ Mn) and Forecasts, By Country

14.8.1. U.S

14.8.1.1. U.S Biobanking Market Revenue (US$ Mn) and Forecasts, By Offering

14.8.1.1.1. Equipment and Accessories

14.8.1.1.2. Consumables

14.8.1.1.3. Software

14.8.1.1.3.1. On-Premise

14.8.1.1.3.2. Cloud

14.8.1.1.4. Services

14.8.1.2. U.S Biobanking Market Revenue (US$ Mn) and Forecasts, By Function

14.8.1.2.1. Sample Collection

14.8.1.2.2. Sample Preparation

14.8.1.2.3. Sample Analysis and Data Management

14.8.1.2.4. Sample Storage

14.8.1.2.5. Sample Transportation

14.8.1.2.6. Others

14.8.1.3. U.S Biobanking Market Revenue (US$ Mn) and Forecasts, By Application

14.8.1.3.1. Drug Discovery

14.8.1.3.2. Clinical Research

14.8.1.3.3. Life Science Research

14.8.1.3.4. Others

14.8.1.4. U.S Biobanking Market Revenue (US$ Mn) and Forecasts, By Biological Sample Type

14.8.1.4.1. Blood Products

14.8.1.4.2. Human Waste

14.8.1.4.3. Cell Lines

14.8.1.4.4. Human Tissue

14.8.1.4.5. Others

14.8.1.5. U.S Biobanking Market Revenue (US$ Mn) and Forecasts, By End Users

14.8.1.5.1. Biobanks

14.8.1.5.2. Pharma and Biotech Companies

14.8.1.5.3. Contract Research Organizations

14.8.1.5.4. Academic and Research Institutions

14.8.1.5.5. Others

14.8.1.6. U.S Biobanking Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

14.8.1.6.1. Online

14.8.1.6.2. Offline

14.8.2. Canada

14.8.2.1. Canada Biobanking Market Revenue (US$ Mn) and Forecasts, By Offering

14.8.2.1.1. Equipment and Accessories

14.8.2.1.2. Consumables

14.8.2.1.3. Software

14.8.2.1.3.1. On-Premise

14.8.2.1.3.2. Cloud

14.8.2.1.4. Services

14.8.2.2. Canada Biobanking Market Revenue (US$ Mn) and Forecasts, By Function

14.8.2.2.1. Sample Collection

14.8.2.2.2. Sample Preparation

14.8.2.2.3. Sample Analysis and Data Management

14.8.2.2.4. Sample Storage

14.8.2.2.5. Sample Transportation

14.8.2.2.6. Others

14.8.2.3. Canada Biobanking Market Revenue (US$ Mn) and Forecasts, By Application

14.8.2.3.1. Drug Discovery

14.8.2.3.2. Clinical Research

14.8.2.3.3. Life Science Research

14.8.2.3.4. Others

14.8.2.4. Canada Biobanking Market Revenue (US$ Mn) and Forecasts, By Biological Sample Type

14.8.2.4.1. Blood Products

14.8.2.4.2. Human Waste

14.8.2.4.3. Cell Lines

14.8.2.4.4. Human Tissue

14.8.2.4.5. Others

14.8.2.5. Canada Biobanking Market Revenue (US$ Mn) and Forecasts, By End Users

14.8.2.5.1. Biobanks

14.8.2.5.2. Pharma and Biotech Companies

14.8.2.5.3. Contract Research Organizations

14.8.2.5.4. Academic and Research Institutions

14.8.2.5.5. Others

14.8.2.6. Canada Biobanking Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

14.8.2.6.1. Online

14.8.2.6.2. Offline

14.8.3. Mexico

14.8.3.1. Mexico Biobanking Market Revenue (US$ Mn) and Forecasts, By Offering

14.8.3.1.1. Equipment and Accessories

14.8.3.1.2. Consumables

14.8.3.1.3. Software

14.8.3.1.3.1. On-Premise

14.8.3.1.3.2. Cloud

14.8.3.1.4. Services

14.8.3.2. Mexico Biobanking Market Revenue (US$ Mn) and Forecasts, By Function

14.8.3.2.1. Sample Collection

14.8.3.2.2. Sample Preparation

14.8.3.2.3. Sample Analysis and Data Management

14.8.3.2.4. Sample Storage

14.8.3.2.5. Sample Transportation

14.8.3.2.6. Others

14.8.3.3. Mexico Biobanking Market Revenue (US$ Mn) and Forecasts, By Application

14.8.3.3.1. Drug Discovery

14.8.3.3.2. Clinical Research

14.8.3.3.3. Life Science Research

14.8.3.3.4. Others

14.8.3.4. Mexico Biobanking Market Revenue (US$ Mn) and Forecasts, By Biological Sample Type

14.8.3.4.1. Blood Products

14.8.3.4.2. Human Waste

14.8.3.4.3. Cell Lines

14.8.3.4.4. Human Tissue

14.8.3.4.5. Others

14.8.3.5. Mexico Biobanking Market Revenue (US$ Mn) and Forecasts, By End Users

14.8.3.5.1. Biobanks

14.8.3.5.2. Pharma and Biotech Companies

14.8.3.5.3. Contract Research Organizations

14.8.3.5.4. Academic and Research Institutions

14.8.3.5.5. Others

14.8.3.6. Mexico Biobanking Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

14.8.3.6.1. Online

14.8.3.6.2. Offline

14.8.4. Rest of North America

14.8.4.1. Rest of North America Biobanking Market Revenue (US$ Mn) and Forecasts, By Offering

14.8.4.1.1. Equipment and Accessories

14.8.4.1.2. Consumables

14.8.4.1.3. Software

14.8.4.1.3.1. On-Premise

14.8.4.1.3.2. Cloud

14.8.4.1.4. Services

14.8.4.2. Rest of North America Biobanking Market Revenue (US$ Mn) and Forecasts, By Function

14.8.4.2.1. Sample Collection

14.8.4.2.2. Sample Preparation

14.8.4.2.3. Sample Analysis and Data Management

14.8.4.2.4. Sample Storage

14.8.4.2.5. Sample Transportation

14.8.4.2.6. Others

14.8.4.3. Rest of North America Biobanking Market Revenue (US$ Mn) and Forecasts, By Application

14.8.4.3.1. Drug Discovery

14.8.4.3.2. Clinical Research

14.8.4.3.3. Life Science Research

14.8.4.3.4. Others

14.8.4.4. Rest of North America Biobanking Market Revenue (US$ Mn) and Forecasts, By Biological Sample Type

14.8.4.4.1. Blood Products

14.8.4.4.2. Human Waste

14.8.4.4.3. Cell Lines

14.8.4.4.4. Human Tissue

14.8.4.4.5. Others

14.8.4.5. Rest of North America Biobanking Market Revenue (US$ Mn) and Forecasts, By End Users

14.8.4.5.1. Biobanks

14.8.4.5.2. Pharma and Biotech Companies

14.8.4.5.3. Contract Research Organizations

14.8.4.5.4. Academic and Research Institutions

14.8.4.5.5. Others

14.8.4.6. Rest of North America Biobanking Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

14.8.4.6.1. Online

14.8.4.6.2. Offline

14.9. Key Segment for Channeling Investments

14.9.1. By Country

14.9.2. By Offering

14.9.3. By Function

14.9.4. By Application

14.9.5. By Biological Sample Type

14.9.6. By End Users

14.9.7. By Distribution Channel

15. Europe Biobanking Market Analysis and Forecasts, 2021 - 2029

15.1. Overview

15.1.1. Europe Biobanking Market Revenue (US$ Mn)

15.2. Europe Biobanking Market Revenue (US$ Mn) and Forecasts, By Offering

15.2.1. Equipment and Accessories

15.2.2. Consumables

15.2.3. Software

15.2.3.1. On-Premise

15.2.3.2. Cloud

15.2.4. Services

15.3. Europe Biobanking Market Revenue (US$ Mn) and Forecasts, By Function

15.3.1. Sample Collection

15.3.2. Sample Preparation

15.3.3. Sample Analysis and Data Management

15.3.4. Sample Storage

15.3.5. Sample Transportation

15.3.6. Others

15.4. Europe Biobanking Market Revenue (US$ Mn) and Forecasts, By Application

15.4.1. Drug Discovery

15.4.2. Clinical Research

15.4.3. Life Science Research

15.4.4. Others

15.5. Europe Biobanking Market Revenue (US$ Mn) and Forecasts, By Biological Sample Type

15.5.1. Blood Products

15.5.2. Human Waste

15.5.3. Cell Lines

15.5.4. Human Tissue

15.5.5. Others

15.6. Europe Biobanking Market Revenue (US$ Mn) and Forecasts, By End Users

15.6.1. Biobanks

15.6.2. Pharma and Biotech Companies

15.6.3. Contract Research Organizations

15.6.4. Academic and Research Institutions

15.6.5. Others

15.7. Europe Biobanking Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

15.7.1. Online

15.7.2. Offline

15.8. Europe Biobanking Market Revenue (US$ Mn) and Forecasts, By Country

15.8.1. France

15.8.1.1. France Biobanking Market Revenue (US$ Mn) and Forecasts, By Offering

15.8.1.1.1. Equipment and Accessories

15.8.1.1.2. Consumables

15.8.1.1.3. Software

15.8.1.1.3.1. On-Premise

15.8.1.1.3.2. Cloud

15.8.1.1.4. Services

15.8.1.2. France Biobanking Market Revenue (US$ Mn) and Forecasts, By Function

15.8.1.2.1. Sample Collection

15.8.1.2.2. Sample Preparation

15.8.1.2.3. Sample Analysis and Data Management

15.8.1.2.4. Sample Storage

15.8.1.2.5. Sample Transportation

15.8.1.2.6. Others

15.8.1.3. France Biobanking Market Revenue (US$ Mn) and Forecasts, By Application

15.8.1.3.1. Drug Discovery

15.8.1.3.2. Clinical Research

15.8.1.3.3. Life Science Research

15.8.1.3.4. Others

15.8.1.4. France Biobanking Market Revenue (US$ Mn) and Forecasts, By Biological Sample Type

15.8.1.4.1. Blood Products

15.8.1.4.2. Human Waste

15.8.1.4.3. Cell Lines

15.8.1.4.4. Human Tissue

15.8.1.4.5. Others

15.8.1.5. France Biobanking Market Revenue (US$ Mn) and Forecasts, By End Users

15.8.1.5.1. Biobanks

15.8.1.5.2. Pharma and Biotech Companies

15.8.1.5.3. Contract Research Organizations

15.8.1.5.4. Academic and Research Institutions

15.8.1.5.5. Others

15.8.1.6. France Biobanking Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

15.8.1.6.1. Online

15.8.1.6.2. Offline

15.8.2. The UK

15.8.2.1. The UK Biobanking Market Revenue (US$ Mn) and Forecasts, By Offering

15.8.2.1.1. Equipment and Accessories

15.8.2.1.2. Consumables

15.8.2.1.3. Software

15.8.2.1.3.1. On-Premise

15.8.2.1.3.2. Cloud

15.8.2.1.4. Services

15.8.2.2. The UK Biobanking Market Revenue (US$ Mn) and Forecasts, By Function

15.8.2.2.1. Sample Collection

15.8.2.2.2. Sample Preparation

15.8.2.2.3. Sample Analysis and Data Management

15.8.2.2.4. Sample Storage

15.8.2.2.5. Sample Transportation

15.8.2.2.6. Others

15.8.2.3. The UK Biobanking Market Revenue (US$ Mn) and Forecasts, By Application

15.8.2.3.1. Drug Discovery

15.8.2.3.2. Clinical Research

15.8.2.3.3. Life Science Research

15.8.2.3.4. Others

15.8.2.4. The UK Biobanking Market Revenue (US$ Mn) and Forecasts, By Biological Sample Type

15.8.2.4.1. Blood Products

15.8.2.4.2. Human Waste

15.8.2.4.3. Cell Lines

15.8.2.4.4. Human Tissue

15.8.2.4.5. Others

15.8.2.5. The UK Biobanking Market Revenue (US$ Mn) and Forecasts, By End Users

15.8.2.5.1. Biobanks

15.8.2.5.2. Pharma and Biotech Companies

15.8.2.5.3. Contract Research Organizations

15.8.2.5.4. Academic and Research Institutions

15.8.2.5.5. Others

15.8.2.6. The UK Biobanking Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

15.8.2.6.1. Online

15.8.2.6.2. Offline

15.8.3. Spain

15.8.3.1. Spain Biobanking Market Revenue (US$ Mn) and Forecasts, By Offering

15.8.3.1.1. Equipment and Accessories

15.8.3.1.2. Consumables

15.8.3.1.3. Software

15.8.3.1.3.1. On-Premise

15.8.3.1.3.2. Cloud

15.8.3.1.4. Services

15.8.3.2. Spain Biobanking Market Revenue (US$ Mn) and Forecasts, By Function

15.8.3.2.1. Sample Collection

15.8.3.2.2. Sample Preparation

15.8.3.2.3. Sample Analysis and Data Management

15.8.3.2.4. Sample Storage

15.8.3.2.5. Sample Transportation

15.8.3.2.6. Others

15.8.3.3. Spain Biobanking Market Revenue (US$ Mn) and Forecasts, By Application

15.8.3.3.1. Drug Discovery

15.8.3.3.2. Clinical Research

15.8.3.3.3. Life Science Research

15.8.3.3.4. Others

15.8.3.4. Spain Biobanking Market Revenue (US$ Mn) and Forecasts, By Biological Sample Type

15.8.3.4.1. Blood Products

15.8.3.4.2. Human Waste

15.8.3.4.3. Cell Lines

15.8.3.4.4. Human Tissue

15.8.3.4.5. Others

15.8.3.5. Spain Biobanking Market Revenue (US$ Mn) and Forecasts, By End Users

15.8.3.5.1. Biobanks

15.8.3.5.2. Pharma and Biotech Companies

15.8.3.5.3. Contract Research Organizations

15.8.3.5.4. Academic and Research Institutions

15.8.3.5.5. Others

15.8.3.6. Spain Biobanking Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

15.8.3.6.1. Online

15.8.3.6.2. Offline

15.8.4. Germany

15.8.4.1. Germany Biobanking Market Revenue (US$ Mn) and Forecasts, By Offering

15.8.4.1.1. Equipment and Accessories

15.8.4.1.2. Consumables

15.8.4.1.3. Software

15.8.4.1.3.1. On-Premise

15.8.4.1.3.2. Cloud

15.8.4.1.4. Services

15.8.4.2. Germany Biobanking Market Revenue (US$ Mn) and Forecasts, By Function

15.8.4.2.1. Sample Collection

15.8.4.2.2. Sample Preparation

15.8.4.2.3. Sample Analysis and Data Management

15.8.4.2.4. Sample Storage

15.8.4.2.5. Sample Transportation

15.8.4.2.6. Others

15.8.4.3. Germany Biobanking Market Revenue (US$ Mn) and Forecasts, By Application

15.8.4.3.1. Drug Discovery

15.8.4.3.2. Clinical Research

15.8.4.3.3. Life Science Research

15.8.4.3.4. Others

15.8.4.4. Germany Biobanking Market Revenue (US$ Mn) and Forecasts, By Biological Sample Type

15.8.4.4.1. Blood Products

15.8.4.4.2. Human Waste

15.8.4.4.3. Cell Lines

15.8.4.4.4. Human Tissue

15.8.4.4.5. Others

15.8.4.5. Germany Biobanking Market Revenue (US$ Mn) and Forecasts, By End Users

15.8.4.5.1. Biobanks

15.8.4.5.2. Pharma and Biotech Companies

15.8.4.5.3. Contract Research Organizations

15.8.4.5.4. Academic and Research Institutions

15.8.4.5.5. Others

15.8.4.6. Germany Biobanking Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

15.8.4.6.1. Online

15.8.4.6.2. Offline

15.8.5. Italy

15.8.5.1. Italy Biobanking Market Revenue (US$ Mn) and Forecasts, By Offering

15.8.5.1.1. Equipment and Accessories

15.8.5.1.2. Consumables

15.8.5.1.3. Software

15.8.5.1.3.1. On-Premise

15.8.5.1.3.2. Cloud

15.8.5.1.4. Services

15.8.5.2. Italy Biobanking Market Revenue (US$ Mn) and Forecasts, By Function

15.8.5.2.1. Sample Collection

15.8.5.2.2. Sample Preparation

15.8.5.2.3. Sample Analysis and Data Management

15.8.5.2.4. Sample Storage

15.8.5.2.5. Sample Transportation

15.8.5.2.6. Others

15.8.5.3. Italy Biobanking Market Revenue (US$ Mn) and Forecasts, By Application

15.8.5.3.1. Drug Discovery

15.8.5.3.2. Clinical Research

15.8.5.3.3. Life Science Research

15.8.5.3.4. Others

15.8.5.4. Italy Biobanking Market Revenue (US$ Mn) and Forecasts, By Biological Sample Type

15.8.5.4.1. Blood Products

15.8.5.4.2. Human Waste

15.8.5.4.3. Cell Lines

15.8.5.4.4. Human Tissue

15.8.5.4.5. Others

15.8.5.5. Italy Biobanking Market Revenue (US$ Mn) and Forecasts, By End Users

15.8.5.5.1. Biobanks

15.8.5.5.2. Pharma and Biotech Companies

15.8.5.5.3. Contract Research Organizations

15.8.5.5.4. Academic and Research Institutions

15.8.5.5.5. Others

15.8.5.6. Italy Biobanking Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

15.8.5.6.1. Online

15.8.5.6.2. Offline

15.8.6. Nordic Countries

15.8.6.1. Nordic Countries Biobanking Market Revenue (US$ Mn) and Forecasts, By Offering

15.8.6.1.1. Equipment and Accessories

15.8.6.1.2. Consumables

15.8.6.1.3. Software

15.8.6.1.3.1. On-Premise

15.8.6.1.3.2. Cloud

15.8.6.1.4. Services

15.8.6.2. Nordic Countries Biobanking Market Revenue (US$ Mn) and Forecasts, By Function

15.8.6.2.1. Sample Collection

15.8.6.2.2. Sample Preparation

15.8.6.2.3. Sample Analysis and Data Management

15.8.6.2.4. Sample Storage

15.8.6.2.5. Sample Transportation

15.8.6.2.6. Others

15.8.6.3. Nordic Countries Biobanking Market Revenue (US$ Mn) and Forecasts, By Application

15.8.6.3.1. Drug Discovery

15.8.6.3.2. Clinical Research

15.8.6.3.3. Life Science Research

15.8.6.3.4. Others

15.8.6.4. Nordic Countries Biobanking Market Revenue (US$ Mn) and Forecasts, By Biological Sample Type

15.8.6.4.1. Blood Products

15.8.6.4.2. Human Waste

15.8.6.4.3. Cell Lines

15.8.6.4.4. Human Tissue

15.8.6.4.5. Others

15.8.6.5. Nordic Countries Biobanking Market Revenue (US$ Mn) and Forecasts, By End Users

15.8.6.5.1. Biobanks

15.8.6.5.2. Pharma and Biotech Companies

15.8.6.5.3. Contract Research Organizations

15.8.6.5.4. Academic and Research Institutions

15.8.6.5.5. Others

15.8.6.6. Nordic Countries Biobanking Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

15.8.6.6.1. Online

15.8.6.6.2. Offline

15.8.6.7. Nordic Countries Biobanking Market Revenue (US$ Mn) and Forecasts, By Country

15.8.6.7.1. Denmark

15.8.6.7.2. Finland

15.8.6.7.3. Iceland

15.8.6.7.4. Sweden

15.8.6.7.5. Norway

15.8.7. Benelux Union

15.8.7.1. Benelux Union Biobanking Market Revenue (US$ Mn) and Forecasts, By Offering

15.8.7.1.1. Equipment and Accessories

15.8.7.1.2. Consumables

15.8.7.1.3. Software

15.8.7.1.3.1. On-Premise

15.8.7.1.3.2. Cloud

15.8.7.1.4. Services

15.8.7.2. Benelux Union Biobanking Market Revenue (US$ Mn) and Forecasts, By Function

15.8.7.2.1. Sample Collection

15.8.7.2.2. Sample Preparation

15.8.7.2.3. Sample Analysis and Data Management

15.8.7.2.4. Sample Storage

15.8.7.2.5. Sample Transportation

15.8.7.2.6. Others

15.8.7.3. Benelux Union Biobanking Market Revenue (US$ Mn) and Forecasts, By Application

15.8.7.3.1. Drug Discovery

15.8.7.3.2. Clinical Research

15.8.7.3.3. Life Science Research

15.8.7.3.4. Others

15.8.7.4. Benelux Union Biobanking Market Revenue (US$ Mn) and Forecasts, By Biological Sample Type

15.8.7.4.1. Blood Products

15.8.7.4.2. Human Waste

15.8.7.4.3. Cell Lines

15.8.7.4.4. Human Tissue

15.8.7.4.5. Others

15.8.7.5. Benelux Union Biobanking Market Revenue (US$ Mn) and Forecasts, By End Users

15.8.7.5.1. Biobanks

15.8.7.5.2. Pharma and Biotech Companies

15.8.7.5.3. Contract Research Organizations

15.8.7.5.4. Academic and Research Institutions

15.8.7.5.5. Others

15.8.7.6. Benelux Union Biobanking Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

15.8.7.6.1. Online

15.8.7.6.2. Offline

15.8.7.7. Benelux Union Biobanking Market Revenue (US$ Mn) and Forecasts, By Country

15.8.7.7.1. Belgium

15.8.7.7.2. The Netherlands

15.8.7.7.3. Luxembourg

15.8.8. Rest of Europe

15.8.8.1. Rest of Europe Biobanking Market Revenue (US$ Mn) and Forecasts, By Offering

15.8.8.1.1. Equipment and Accessories

15.8.8.1.2. Consumables

15.8.8.1.3. Software

15.8.8.1.3.1. On-Premise

15.8.8.1.3.2. Cloud

15.8.8.1.4. Services

15.8.8.2. Rest of Europe Biobanking Market Revenue (US$ Mn) and Forecasts, By Function

15.8.8.2.1. Sample Collection

15.8.8.2.2. Sample Preparation

15.8.8.2.3. Sample Analysis and Data Management

15.8.8.2.4. Sample Storage

15.8.8.2.5. Sample Transportation

15.8.8.2.6. Others

15.8.8.3. Rest of Europe Biobanking Market Revenue (US$ Mn) and Forecasts, By Application

15.8.8.3.1. Drug Discovery

15.8.8.3.2. Clinical Research

15.8.8.3.3. Life Science Research

15.8.8.3.4. Others

15.8.8.4. Rest of Europe Biobanking Market Revenue (US$ Mn) and Forecasts, By Biological Sample Type

15.8.8.4.1. Blood Products

15.8.8.4.2. Human Waste

15.8.8.4.3. Cell Lines

15.8.8.4.4. Human Tissue

15.8.8.4.5. Others

15.8.8.5. Rest of Europe Biobanking Market Revenue (US$ Mn) and Forecasts, By End Users

15.8.8.5.1. Biobanks

15.8.8.5.2. Pharma and Biotech Companies

15.8.8.5.3. Contract Research Organizations

15.8.8.5.4. Academic and Research Institutions

15.8.8.5.5. Others

15.8.8.6. Rest of Europe Biobanking Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

15.8.8.6.1. Online

15.8.8.6.2. Offline

15.9. Key Segment for Channeling Investments

15.9.1. By Country

15.9.2. By Offering

15.9.3. By Function

15.9.4. By Application

15.9.5. By Biological Sample Type

15.9.6. By End Users

15.9.7. By Distribution Channel

16. Asia Pacific Biobanking Market Analysis and Forecasts, 2021 - 2029

16.1. Overview

16.1.1. Asia Pacific Biobanking Market Revenue (US$ Mn)

16.2. Asia Pacific Biobanking Market Revenue (US$ Mn) and Forecasts, By Offering

16.2.1. Equipment and Accessories

16.2.2. Consumables

16.2.3. Software

16.2.3.1. On-Premise

16.2.3.2. Cloud

16.2.4. Services

16.3. Asia Pacific Biobanking Market Revenue (US$ Mn) and Forecasts, By Function

16.3.1. Sample Collection

16.3.2. Sample Preparation

16.3.3. Sample Analysis and Data Management

16.3.4. Sample Storage

16.3.5. Sample Transportation

16.3.6. Others

16.4. Asia Pacific Biobanking Market Revenue (US$ Mn) and Forecasts, By Application

16.4.1. Drug Discovery

16.4.2. Clinical Research

16.4.3. Life Science Research

16.4.4. Others

16.5. Asia Pacific Biobanking Market Revenue (US$ Mn) and Forecasts, By Biological Sample Type

16.5.1. Blood Products

16.5.2. Human Waste

16.5.3. Cell Lines

16.5.4. Human Tissue

16.5.5. Others

16.6. Asia Pacific Biobanking Market Revenue (US$ Mn) and Forecasts, By End Users

16.6.1. Biobanks

16.6.2. Pharma and Biotech Companies

16.6.3. Contract Research Organizations

16.6.4. Academic and Research Institutions

16.6.5. Others

16.7. Asia Pacific Biobanking Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

16.7.1. Online

16.7.2. Offline

16.8. Asia Pacific Biobanking Market Revenue (US$ Mn) and Forecasts, By Country

16.8.1. China

16.8.1.1. China Biobanking Market Revenue (US$ Mn) and Forecasts, By Offering

16.8.1.1.1. Equipment and Accessories

16.8.1.1.2. Consumables

16.8.1.1.3. Software

16.8.1.1.3.1. On-Premise

16.8.1.1.3.2. Cloud

16.8.1.1.4. Services

16.8.1.2. China Biobanking Market Revenue (US$ Mn) and Forecasts, By Function

16.8.1.2.1. Sample Collection

16.8.1.2.2. Sample Preparation

16.8.1.2.3. Sample Analysis and Data Management

16.8.1.2.4. Sample Storage

16.8.1.2.5. Sample Transportation

16.8.1.2.6. Others

16.8.1.3. China Biobanking Market Revenue (US$ Mn) and Forecasts, By Application

16.8.1.3.1. Drug Discovery

16.8.1.3.2. Clinical Research

16.8.1.3.3. Life Science Research

16.8.1.3.4. Others

16.8.1.4. China Biobanking Market Revenue (US$ Mn) and Forecasts, By Biological Sample Type

16.8.1.4.1. Blood Products

16.8.1.4.2. Human Waste

16.8.1.4.3. Cell Lines

16.8.1.4.4. Human Tissue

16.8.1.4.5. Others

16.8.1.5. China Biobanking Market Revenue (US$ Mn) and Forecasts, By End Users

16.8.1.5.1. Biobanks

16.8.1.5.2. Pharma and Biotech Companies

16.8.1.5.3. Contract Research Organizations

16.8.1.5.4. Academic and Research Institutions

16.8.1.5.5. Others

16.8.1.6. China Biobanking Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

16.8.1.6.1. Online

16.8.1.6.2. Offline

16.8.2. Japan

16.8.2.1. Japan Biobanking Market Revenue (US$ Mn) and Forecasts, By Offering

16.8.2.1.1. Equipment and Accessories

16.8.2.1.2. Consumables

16.8.2.1.3. Software

16.8.2.1.3.1. On-Premise

16.8.2.1.3.2. Cloud

16.8.2.1.4. Services

16.8.2.2. Japan Biobanking Market Revenue (US$ Mn) and Forecasts, By Function

16.8.2.2.1. Sample Collection

16.8.2.2.2. Sample Preparation

16.8.2.2.3. Sample Analysis and Data Management

16.8.2.2.4. Sample Storage

16.8.2.2.5. Sample Transportation

16.8.2.2.6. Others

16.8.2.3. Japan Biobanking Market Revenue (US$ Mn) and Forecasts, By Application

16.8.2.3.1. Drug Discovery

16.8.2.3.2. Clinical Research

16.8.2.3.3. Life Science Research

16.8.2.3.4. Others

16.8.2.4. Japan Biobanking Market Revenue (US$ Mn) and Forecasts, By Biological Sample Type

16.8.2.4.1. Blood Products

16.8.2.4.2. Human Waste

16.8.2.4.3. Cell Lines

16.8.2.4.4. Human Tissue

16.8.2.4.5. Others

16.8.2.5. Japan Biobanking Market Revenue (US$ Mn) and Forecasts, By End Users

16.8.2.5.1. Biobanks

16.8.2.5.2. Pharma and Biotech Companies

16.8.2.5.3. Contract Research Organizations

16.8.2.5.4. Academic and Research Institutions

16.8.2.5.5. Others

16.8.2.6. Japan Biobanking Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

16.8.2.6.1. Online

16.8.2.6.2. Offline

16.8.3. India

16.8.3.1. India Biobanking Market Revenue (US$ Mn) and Forecasts, By Offering

16.8.3.1.1. Equipment and Accessories

16.8.3.1.2. Consumables

16.8.3.1.3. Software

16.8.3.1.3.1. On-Premise

16.8.3.1.3.2. Cloud

16.8.3.1.4. Services

16.8.3.2. India Biobanking Market Revenue (US$ Mn) and Forecasts, By Function

16.8.3.2.1. Sample Collection

16.8.3.2.2. Sample Preparation

16.8.3.2.3. Sample Analysis and Data Management

16.8.3.2.4. Sample Storage

16.8.3.2.5. Sample Transportation

16.8.3.2.6. Others

16.8.3.3. India Biobanking Market Revenue (US$ Mn) and Forecasts, By Application

16.8.3.3.1. Drug Discovery

16.8.3.3.2. Clinical Research

16.8.3.3.3. Life Science Research

16.8.3.3.4. Others

16.8.3.4. India Biobanking Market Revenue (US$ Mn) and Forecasts, By Biological Sample Type

16.8.3.4.1. Blood Products

16.8.3.4.2. Human Waste

16.8.3.4.3. Cell Lines

16.8.3.4.4. Human Tissue

16.8.3.4.5. Others

16.8.3.5. India Biobanking Market Revenue (US$ Mn) and Forecasts, By End Users

16.8.3.5.1. Biobanks

16.8.3.5.2. Pharma and Biotech Companies

16.8.3.5.3. Contract Research Organizations

16.8.3.5.4. Academic and Research Institutions

16.8.3.5.5. Others

16.8.3.6. India Biobanking Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

16.8.3.6.1. Online

16.8.3.6.2. Offline

16.8.4. New Zealand

16.8.4.1. New Zealand Biobanking Market Revenue (US$ Mn) and Forecasts, By Offering

16.8.4.1.1. Equipment and Accessories

16.8.4.1.2. Consumables

16.8.4.1.3. Software

16.8.4.1.3.1. On-Premise

16.8.4.1.3.2. Cloud

16.8.4.1.4. Services

16.8.4.2. New Zealand Biobanking Market Revenue (US$ Mn) and Forecasts, By Function

16.8.4.2.1. Sample Collection

16.8.4.2.2. Sample Preparation

16.8.4.2.3. Sample Analysis and Data Management

16.8.4.2.4. Sample Storage

16.8.4.2.5. Sample Transportation

16.8.4.2.6. Others

16.8.4.3. New Zealand Biobanking Market Revenue (US$ Mn) and Forecasts, By Application

16.8.4.3.1. Drug Discovery

16.8.4.3.2. Clinical Research

16.8.4.3.3. Life Science Research

16.8.4.3.4. Others

16.8.4.4. New Zealand Biobanking Market Revenue (US$ Mn) and Forecasts, By Biological Sample Type

16.8.4.4.1. Blood Products

16.8.4.4.2. Human Waste

16.8.4.4.3. Cell Lines

16.8.4.4.4. Human Tissue

16.8.4.4.5. Others

16.8.4.5. New Zealand Biobanking Market Revenue (US$ Mn) and Forecasts, By End Users

16.8.4.5.1. Biobanks

16.8.4.5.2. Pharma and Biotech Companies

16.8.4.5.3. Contract Research Organizations

16.8.4.5.4. Academic and Research Institutions

16.8.4.5.5. Others

16.8.4.6. New Zealand Biobanking Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

16.8.4.6.1. Online

16.8.4.6.2. Offline

16.8.5. Australia

16.8.5.1. Australia Biobanking Market Revenue (US$ Mn) and Forecasts, By Offering

16.8.5.1.1. Equipment and Accessories

16.8.5.1.2. Consumables

16.8.5.1.3. Software

16.8.5.1.3.1. On-Premise

16.8.5.1.3.2. Cloud

16.8.5.1.4. Services

16.8.5.2. Australia Biobanking Market Revenue (US$ Mn) and Forecasts, By Function

16.8.5.2.1. Sample Collection

16.8.5.2.2. Sample Preparation

16.8.5.2.3. Sample Analysis and Data Management

16.8.5.2.4. Sample Storage

16.8.5.2.5. Sample Transportation

16.8.5.2.6. Others

16.8.5.3. Australia Biobanking Market Revenue (US$ Mn) and Forecasts, By Application

16.8.5.3.1. Drug Discovery

16.8.5.3.2. Clinical Research

16.8.5.3.3. Life Science Research

16.8.5.3.4. Others

16.8.5.4. Australia Biobanking Market Revenue (US$ Mn) and Forecasts, By Biological Sample Type

16.8.5.4.1. Blood Products

16.8.5.4.2. Human Waste

16.8.5.4.3. Cell Lines

16.8.5.4.4. Human Tissue

16.8.5.4.5. Others

16.8.5.5. Australia Biobanking Market Revenue (US$ Mn) and Forecasts, By End Users

16.8.5.5.1. Biobanks

16.8.5.5.2. Pharma and Biotech Companies

16.8.5.5.3. Contract Research Organizations

16.8.5.5.4. Academic and Research Institutions

16.8.5.5.5. Others

16.8.5.6. Australia Biobanking Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

16.8.5.6.1. Online

16.8.5.6.2. Offline

16.8.6. South Korea

16.8.6.1. South Korea Biobanking Market Revenue (US$ Mn) and Forecasts, By Offering

16.8.6.1.1. Equipment and Accessories

16.8.6.1.2. Consumables

16.8.6.1.3. Software

16.8.6.1.3.1. On-Premise

16.8.6.1.3.2. Cloud

16.8.6.1.4. Services

16.8.6.2. South Korea Biobanking Market Revenue (US$ Mn) and Forecasts, By Function

16.8.6.2.1. Sample Collection

16.8.6.2.2. Sample Preparation

16.8.6.2.3. Sample Analysis and Data Management

16.8.6.2.4. Sample Storage

16.8.6.2.5. Sample Transportation

16.8.6.2.6. Others

16.8.6.3. South Korea Biobanking Market Revenue (US$ Mn) and Forecasts, By Application

16.8.6.3.1. Drug Discovery

16.8.6.3.2. Clinical Research

16.8.6.3.3. Life Science Research

16.8.6.3.4. Others

16.8.6.4. South Korea Biobanking Market Revenue (US$ Mn) and Forecasts, By Biological Sample Type

16.8.6.4.1. Blood Products

16.8.6.4.2. Human Waste

16.8.6.4.3. Cell Lines

16.8.6.4.4. Human Tissue

16.8.6.4.5. Others

16.8.6.5. South Korea Biobanking Market Revenue (US$ Mn) and Forecasts, By End Users

16.8.6.5.1. Biobanks

16.8.6.5.2. Pharma and Biotech Companies

16.8.6.5.3. Contract Research Organizations

16.8.6.5.4. Academic and Research Institutions

16.8.6.5.5. Others

16.8.6.6. South Korea Biobanking Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

16.8.6.6.1. Online

16.8.6.6.2. Offline

16.8.7. Southeast Asia

16.8.7.1. Southeast Asia Biobanking Market Revenue (US$ Mn) and Forecasts, By Offering

16.8.7.1.1. Equipment and Accessories

16.8.7.1.2. Consumables

16.8.7.1.3. Software

16.8.7.1.3.1. On-Premise

16.8.7.1.3.2. Cloud

16.8.7.1.4. Services

16.8.7.2. Southeast Asia Biobanking Market Revenue (US$ Mn) and Forecasts, By Function

16.8.7.2.1. Sample Collection

16.8.7.2.2. Sample Preparation

16.8.7.2.3. Sample Analysis and Data Management

16.8.7.2.4. Sample Storage

16.8.7.2.5. Sample Transportation

16.8.7.2.6. Others

16.8.7.3. Southeast Asia Biobanking Market Revenue (US$ Mn) and Forecasts, By Application

16.8.7.3.1. Drug Discovery

16.8.7.3.2. Clinical Research

16.8.7.3.3. Life Science Research

16.8.7.3.4. Others

16.8.7.4. Southeast Asia Biobanking Market Revenue (US$ Mn) and Forecasts, By Biological Sample Type

16.8.7.4.1. Blood Products

16.8.7.4.2. Human Waste

16.8.7.4.3. Cell Lines

16.8.7.4.4. Human Tissue

16.8.7.4.5. Others

16.8.7.5. Southeast Asia Biobanking Market Revenue (US$ Mn) and Forecasts, By End Users

16.8.7.5.1. Biobanks

16.8.7.5.2. Pharma and Biotech Companies

16.8.7.5.3. Contract Research Organizations

16.8.7.5.4. Academic and Research Institutions

16.8.7.5.5. Others

16.8.7.6. Southeast Asia Biobanking Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

16.8.7.6.1. Online

16.8.7.6.2. Offline

16.8.7.7. Southeast Asia Biobanking Market Revenue (US$ Mn) and Forecasts, By Country

16.8.7.7.1. Indonesia

16.8.7.7.2. Thailand

16.8.7.7.3. Malaysia

16.8.7.7.4. Singapore

16.8.7.7.5. Rest of Southeast Asia

16.8.8. Rest of Asia Pacific

16.8.8.1. Rest of Asia Pacific Biobanking Market Revenue (US$ Mn) and Forecasts, By Offering

16.8.8.1.1. Equipment and Accessories

16.8.8.1.2. Consumables

16.8.8.1.3. Software

16.8.8.1.3.1. On-Premise

16.8.8.1.3.2. Cloud

16.8.8.1.4. Services

16.8.8.2. Rest of Asia Pacific Biobanking Market Revenue (US$ Mn) and Forecasts, By Function

16.8.8.2.1. Sample Collection

16.8.8.2.2. Sample Preparation

16.8.8.2.3. Sample Analysis and Data Management

16.8.8.2.4. Sample Storage

16.8.8.2.5. Sample Transportation

16.8.8.2.6. Others

16.8.8.3. Rest of Asia Pacific Biobanking Market Revenue (US$ Mn) and Forecasts, By Application

16.8.8.3.1. Drug Discovery

16.8.8.3.2. Clinical Research

16.8.8.3.3. Life Science Research

16.8.8.3.4. Others

16.8.8.4. Rest of Asia Pacific Biobanking Market Revenue (US$ Mn) and Forecasts, By Biological Sample Type

16.8.8.4.1. Blood Products

16.8.8.4.2. Human Waste

16.8.8.4.3. Cell Lines

16.8.8.4.4. Human Tissue

16.8.8.4.5. Others

16.8.8.5. Rest of Asia Pacific Biobanking Market Revenue (US$ Mn) and Forecasts, By End Users

16.8.8.5.1. Biobanks

16.8.8.5.2. Pharma and Biotech Companies

16.8.8.5.3. Contract Research Organizations

16.8.8.5.4. Academic and Research Institutions

16.8.8.5.5. Others

16.8.8.6. Rest of Asia Pacific Biobanking Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

16.8.8.6.1. Online

16.8.8.6.2. Offline

16.9. Key Segment for Channeling Investments

16.9.1. By Country

16.9.2. By Offering

16.9.3. By Function

16.9.4. By Application

16.9.5. By Biological Sample Type

16.9.6. By End Users

16.9.7. By Distribution Channel

17. Middle East and Africa Biobanking Market Analysis and Forecasts, 2021 - 2029

17.1. Overview

17.1.1. Middle East and Africa Biobanking Market Revenue (US$ Mn)

17.2. Middle East and Africa Biobanking Market Revenue (US$ Mn) and Forecasts, By Offering

17.2.1. Equipment and Accessories

17.2.2. Consumables

17.2.3. Software

17.2.3.1. On-Premise

17.2.3.2. Cloud

17.2.4. Services

17.3. Middle East and Africa Biobanking Market Revenue (US$ Mn) and Forecasts, By Function

17.3.1. Sample Collection

17.3.2. Sample Preparation

17.3.3. Sample Analysis and Data Management

17.3.4. Sample Storage

17.3.5. Sample Transportation

17.3.6. Others

17.4. Middle East and Africa Biobanking Market Revenue (US$ Mn) and Forecasts, By Application

17.4.1. Drug Discovery

17.4.2. Clinical Research

17.4.3. Life Science Research

17.4.4. Others

17.5. Middle East and Africa Biobanking Market Revenue (US$ Mn) and Forecasts, By Biological Sample Type

17.5.1. Blood Products

17.5.2. Human Waste

17.5.3. Cell Lines

17.5.4. Human Tissue

17.5.5. Others

17.6. Middle East and Africa Biobanking Market Revenue (US$ Mn) and Forecasts, By End Users

17.6.1. Biobanks

17.6.2. Pharma and Biotech Companies

17.6.3. Contract Research Organizations

17.6.4. Academic and Research Institutions

17.6.5. Others

17.7. Middle East and Africa Biobanking Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

17.7.1. Online

17.7.2. Offline

17.8. Middle East and Africa Biobanking Market Revenue (US$ Mn) and Forecasts, By Country

17.8.1. Saudi Arabia

17.8.1.1. Saudi Arabia Biobanking Market Revenue (US$ Mn) and Forecasts, By Offering

17.8.1.1.1. Equipment and Accessories

17.8.1.1.2. Consumables

17.8.1.1.3. Software

17.8.1.1.3.1. On-Premise

17.8.1.1.3.2. Cloud

17.8.1.1.4. Services

17.8.1.2. Saudi Arabia Biobanking Market Revenue (US$ Mn) and Forecasts, By Function

17.8.1.2.1. Sample Collection

17.8.1.2.2. Sample Preparation

17.8.1.2.3. Sample Analysis and Data Management

17.8.1.2.4. Sample Storage

17.8.1.2.5. Sample Transportation

17.8.1.2.6. Others

17.8.1.3. Saudi Arabia Biobanking Market Revenue (US$ Mn) and Forecasts, By Application

17.8.1.3.1. Drug Discovery

17.8.1.3.2. Clinical Research

17.8.1.3.3. Life Science Research

17.8.1.3.4. Others

17.8.1.4. Saudi Arabia Biobanking Market Revenue (US$ Mn) and Forecasts, By Biological Sample Type

17.8.1.4.1. Blood Products

17.8.1.4.2. Human Waste

17.8.1.4.3. Cell Lines

17.8.1.4.4. Human Tissue

17.8.1.4.5. Others

17.8.1.5. Saudi Arabia Biobanking Market Revenue (US$ Mn) and Forecasts, By End Users

17.8.1.5.1. Biobanks

17.8.1.5.2. Pharma and Biotech Companies

17.8.1.5.3. Contract Research Organizations

17.8.1.5.4. Academic and Research Institutions

17.8.1.5.5. Others

17.8.1.6. Saudi Arabia Biobanking Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

17.8.1.6.1. Online

17.8.1.6.2. Offline

17.8.2. UAE

17.8.2.1. UAE Biobanking Market Revenue (US$ Mn) and Forecasts, By Offering

17.8.2.1.1. Equipment and Accessories

17.8.2.1.2. Consumables

17.8.2.1.3. Software

17.8.2.1.3.1. On-Premise

17.8.2.1.3.2. Cloud

17.8.2.1.4. Services

17.8.2.2. UAE Biobanking Market Revenue (US$ Mn) and Forecasts, By Function

17.8.2.2.1. Sample Collection

17.8.2.2.2. Sample Preparation

17.8.2.2.3. Sample Analysis and Data Management

17.8.2.2.4. Sample Storage

17.8.2.2.5. Sample Transportation

17.8.2.2.6. Others

17.8.2.3. UAE Biobanking Market Revenue (US$ Mn) and Forecasts, By Application

17.8.2.3.1. Drug Discovery

17.8.2.3.2. Clinical Research

17.8.2.3.3. Life Science Research

17.8.2.3.4. Others

17.8.2.4. UAE Biobanking Market Revenue (US$ Mn) and Forecasts, By Biological Sample Type

17.8.2.4.1. Blood Products

17.8.2.4.2. Human Waste

17.8.2.4.3. Cell Lines

17.8.2.4.4. Human Tissue

17.8.2.4.5. Others

17.8.2.5. UAE Biobanking Market Revenue (US$ Mn) and Forecasts, By End Users

17.8.2.5.1. Biobanks

17.8.2.5.2. Pharma and Biotech Companies

17.8.2.5.3. Contract Research Organizations

17.8.2.5.4. Academic and Research Institutions

17.8.2.5.5. Others

17.8.2.6. UAE Biobanking Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

17.8.2.6.1. Online

17.8.2.6.2. Offline

17.8.3. Egypt

17.8.3.1. Egypt Biobanking Market Revenue (US$ Mn) and Forecasts, By Offering

17.8.3.1.1. Equipment and Accessories

17.8.3.1.2. Consumables

17.8.3.1.3. Software

17.8.3.1.3.1. On-Premise

17.8.3.1.3.2. Cloud

17.8.3.1.4. Services

17.8.3.2. Egypt Biobanking Market Revenue (US$ Mn) and Forecasts, By Function

17.8.3.2.1. Sample Collection

17.8.3.2.2. Sample Preparation

17.8.3.2.3. Sample Analysis and Data Management

17.8.3.2.4. Sample Storage

17.8.3.2.5. Sample Transportation

17.8.3.2.6. Others

17.8.3.3. Egypt Biobanking Market Revenue (US$ Mn) and Forecasts, By Application

17.8.3.3.1. Drug Discovery

17.8.3.3.2. Clinical Research

17.8.3.3.3. Life Science Research

17.8.3.3.4. Others

17.8.3.4. Egypt Biobanking Market Revenue (US$ Mn) and Forecasts, By Biological Sample Type

17.8.3.4.1. Blood Products

17.8.3.4.2. Human Waste

17.8.3.4.3. Cell Lines

17.8.3.4.4. Human Tissue

17.8.3.4.5. Others

17.8.3.5. Egypt Biobanking Market Revenue (US$ Mn) and Forecasts, By End Users

17.8.3.5.1. Biobanks

17.8.3.5.2. Pharma and Biotech Companies

17.8.3.5.3. Contract Research Organizations

17.8.3.5.4. Academic and Research Institutions

17.8.3.5.5. Others

17.8.3.6. Egypt Biobanking Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

17.8.3.6.1. Online

17.8.3.6.2. Offline

17.8.4. Kuwait

17.8.4.1. Kuwait Biobanking Market Revenue (US$ Mn) and Forecasts, By Offering

17.8.4.1.1. Equipment and Accessories

17.8.4.1.2. Consumables

17.8.4.1.3. Software

17.8.4.1.3.1. On-Premise

17.8.4.1.3.2. Cloud

17.8.4.1.4. Services

17.8.4.2. Kuwait Biobanking Market Revenue (US$ Mn) and Forecasts, By Function

17.8.4.2.1. Sample Collection

17.8.4.2.2. Sample Preparation

17.8.4.2.3. Sample Analysis and Data Management

17.8.4.2.4. Sample Storage

17.8.4.2.5. Sample Transportation

17.8.4.2.6. Others

17.8.4.3. Kuwait Biobanking Market Revenue (US$ Mn) and Forecasts, By Application

17.8.4.3.1. Drug Discovery

17.8.4.3.2. Clinical Research

17.8.4.3.3. Life Science Research

17.8.4.3.4. Others

17.8.4.4. Kuwait Biobanking Market Revenue (US$ Mn) and Forecasts, By Biological Sample Type

17.8.4.4.1. Blood Products

17.8.4.4.2. Human Waste

17.8.4.4.3. Cell Lines

17.8.4.4.4. Human Tissue

17.8.4.4.5. Others

17.8.4.5. Kuwait Biobanking Market Revenue (US$ Mn) and Forecasts, By End Users

17.8.4.5.1. Biobanks

17.8.4.5.2. Pharma and Biotech Companies

17.8.4.5.3. Contract Research Organizations

17.8.4.5.4. Academic and Research Institutions

17.8.4.5.5. Others

17.8.4.6. Kuwait Biobanking Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

17.8.4.6.1. Online

17.8.4.6.2. Offline

17.8.5. South Africa

17.8.5.1. South Africa Biobanking Market Revenue (US$ Mn) and Forecasts, By Offering

17.8.5.1.1. Equipment and Accessories

17.8.5.1.2. Consumables

17.8.5.1.3. Software

17.8.5.1.3.1. On-Premise

17.8.5.1.3.2. Cloud

17.8.5.1.4. Services

17.8.5.2. South Africa Biobanking Market Revenue (US$ Mn) and Forecasts, By Function

17.8.5.2.1. Sample Collection

17.8.5.2.2. Sample Preparation

17.8.5.2.3. Sample Analysis and Data Management

17.8.5.2.4. Sample Storage

17.8.5.2.5. Sample Transportation

17.8.5.2.6. Others

17.8.5.3. South Africa Biobanking Market Revenue (US$ Mn) and Forecasts, By Application

17.8.5.3.1. Drug Discovery

17.8.5.3.2. Clinical Research

17.8.5.3.3. Life Science Research

17.8.5.3.4. Others

17.8.5.4. South Africa Biobanking Market Revenue (US$ Mn) and Forecasts, By Biological Sample Type

17.8.5.4.1. Blood Products

17.8.5.4.2. Human Waste

17.8.5.4.3. Cell Lines

17.8.5.4.4. Human Tissue

17.8.5.4.5. Others

17.8.5.5. South Africa Biobanking Market Revenue (US$ Mn) and Forecasts, By End Users

17.8.5.5.1. Biobanks

17.8.5.5.2. Pharma and Biotech Companies

17.8.5.5.3. Contract Research Organizations

17.8.5.5.4. Academic and Research Institutions

17.8.5.5.5. Others

17.8.5.6. South Africa Biobanking Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

17.8.5.6.1. Online

17.8.5.6.2. Offline

17.8.6. Rest of Middle East & Africa

17.8.6.1. Rest of Middle East & Africa Biobanking Market Revenue (US$ Mn) and Forecasts, By Offering

17.8.6.1.1. Equipment and Accessories

17.8.6.1.2. Consumables

17.8.6.1.3. Software

17.8.6.1.3.1. On-Premise

17.8.6.1.3.2. Cloud

17.8.6.1.4. Services

17.8.6.2. Rest of Middle East & Africa Biobanking Market Revenue (US$ Mn) and Forecasts, By Function

17.8.6.2.1. Sample Collection

17.8.6.2.2. Sample Preparation

17.8.6.2.3. Sample Analysis and Data Management

17.8.6.2.4. Sample Storage

17.8.6.2.5. Sample Transportation

17.8.6.2.6. Others

17.8.6.3. Rest of Middle East & Africa Biobanking Market Revenue (US$ Mn) and Forecasts, By Application

17.8.6.3.1. Drug Discovery

17.8.6.3.2. Clinical Research

17.8.6.3.3. Life Science Research

17.8.6.3.4. Others

17.8.6.4. Rest of Middle East & Africa Biobanking Market Revenue (US$ Mn) and Forecasts, By Biological Sample Type

17.8.6.4.1. Blood Products

17.8.6.4.2. Human Waste

17.8.6.4.3. Cell Lines

17.8.6.4.4. Human Tissue

17.8.6.4.5. Others

17.8.6.5. Rest of Middle East & Africa Biobanking Market Revenue (US$ Mn) and Forecasts, By End Users

17.8.6.5.1. Biobanks

17.8.6.5.2. Pharma and Biotech Companies

17.8.6.5.3. Contract Research Organizations

17.8.6.5.4. Academic and Research Institutions

17.8.6.5.5. Others

17.8.6.6. Rest of Middle East & Africa Biobanking Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

17.8.6.6.1. Online

17.8.6.6.2. Offline

17.9. Key Segment for Channeling Investments

17.9.1. By Country

17.9.2. By Offering

17.9.3. By Function

17.9.4. By Application

17.9.5. By Biological Sample Type

17.9.6. By End Users

17.9.7. By Distribution Channel

18. Latin America Biobanking Market Analysis and Forecasts, 2021 - 2029

18.1. Overview

18.1.1. Latin America Biobanking Market Revenue (US$ Mn)

18.2. Latin America Biobanking Market Revenue (US$ Mn) and Forecasts, By Offering

18.2.1. Equipment and Accessories

18.2.2. Consumables

18.2.3. Software

18.2.3.1. On-Premise

18.2.3.2. Cloud

18.2.4. Services

18.3. Latin America Biobanking Market Revenue (US$ Mn) and Forecasts, By Function

18.3.1. Sample Collection

18.3.2. Sample Preparation

18.3.3. Sample Analysis and Data Management

18.3.4. Sample Storage

18.3.5. Sample Transportation

18.3.6. Others

18.4. Latin America Biobanking Market Revenue (US$ Mn) and Forecasts, By Application

18.4.1. Drug Discovery

18.4.2. Clinical Research

18.4.3. Life Science Research

18.4.4. Others

18.5. Latin America Biobanking Market Revenue (US$ Mn) and Forecasts, By Biological Sample Type

18.5.1. Blood Products

18.5.2. Human Waste

18.5.3. Cell Lines

18.5.4. Human Tissue

18.5.5. Others

18.6. Latin America Biobanking Market Revenue (US$ Mn) and Forecasts, By End Users

18.6.1. Biobanks

18.6.2. Pharma and Biotech Companies

18.6.3. Contract Research Organizations

18.6.4. Academic and Research Institutions

18.6.5. Others

18.7. Latin America Biobanking Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

18.7.1. Online

18.7.2. Offline

18.8. Latin America Biobanking Market Revenue (US$ Mn) and Forecasts, By Country

18.8.1. Brazil

18.8.1.1. Brazil Biobanking Market Revenue (US$ Mn) and Forecasts, By Offering

18.8.1.1.1. Equipment and Accessories

18.8.1.1.2. Consumables

18.8.1.1.3. Software

18.8.1.1.3.1. On-Premise

18.8.1.1.3.2. Cloud

18.8.1.1.4. Services

18.8.1.2. Brazil Biobanking Market Revenue (US$ Mn) and Forecasts, By Function

18.8.1.2.1. Sample Collection

18.8.1.2.2. Sample Preparation

18.8.1.2.3. Sample Analysis and Data Management

18.8.1.2.4. Sample Storage

18.8.1.2.5. Sample Transportation

18.8.1.2.6. Others

18.8.1.3. Brazil Biobanking Market Revenue (US$ Mn) and Forecasts, By Application

18.8.1.3.1. Drug Discovery

18.8.1.3.2. Clinical Research

18.8.1.3.3. Life Science Research

18.8.1.3.4. Others

18.8.1.4. Brazil Biobanking Market Revenue (US$ Mn) and Forecasts, By Biological Sample Type

18.8.1.4.1. Blood Products

18.8.1.4.2. Human Waste

18.8.1.4.3. Cell Lines

18.8.1.4.4. Human Tissue

18.8.1.4.5. Others

18.8.1.5. Brazil Biobanking Market Revenue (US$ Mn) and Forecasts, By End Users

18.8.1.5.1. Biobanks

18.8.1.5.2. Pharma and Biotech Companies

18.8.1.5.3. Contract Research Organizations

18.8.1.5.4. Academic and Research Institutions

18.8.1.5.5. Others

18.8.1.6. Brazil Biobanking Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

18.8.1.6.1. Online

18.8.1.6.2. Offline

18.8.2. Argentina

18.8.2.1. Argentina Biobanking Market Revenue (US$ Mn) and Forecasts, By Offering

18.8.2.1.1. Equipment and Accessories

18.8.2.1.2. Consumables

18.8.2.1.3. Software

18.8.2.1.3.1. On-Premise

18.8.2.1.3.2. Cloud

18.8.2.1.4. Services

18.8.2.2. Argentina Biobanking Market Revenue (US$ Mn) and Forecasts, By Function

18.8.2.2.1. Sample Collection

18.8.2.2.2. Sample Preparation

18.8.2.2.3. Sample Analysis and Data Management

18.8.2.2.4. Sample Storage

18.8.2.2.5. Sample Transportation

18.8.2.2.6. Others

18.8.2.3. Argentina Biobanking Market Revenue (US$ Mn) and Forecasts, By Application

18.8.2.3.1. Drug Discovery

18.8.2.3.2. Clinical Research

18.8.2.3.3. Life Science Research

18.8.2.3.4. Others

18.8.2.4. Argentina Biobanking Market Revenue (US$ Mn) and Forecasts, By Biological Sample Type

18.8.2.4.1. Blood Products

18.8.2.4.2. Human Waste

18.8.2.4.3. Cell Lines

18.8.2.4.4. Human Tissue

18.8.2.4.5. Others

18.8.2.5. Argentina Biobanking Market Revenue (US$ Mn) and Forecasts, By End Users

18.8.2.5.1. Biobanks

18.8.2.5.2. Pharma and Biotech Companies

18.8.2.5.3. Contract Research Organizations

18.8.2.5.4. Academic and Research Institutions

18.8.2.5.5. Others

18.8.2.6. Argentina Biobanking Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

18.8.2.6.1. Online

18.8.2.6.2. Offline

18.8.3. Rest of Latin America

18.8.3.1. Rest of Latin America Biobanking Market Revenue (US$ Mn) and Forecasts, By Offering

18.8.3.1.1. Equipment and Accessories

18.8.3.1.2. Consumables

18.8.3.1.3. Software

18.8.3.1.3.1. On-Premise

18.8.3.1.3.2. Cloud

18.8.3.1.4. Services

18.8.3.2. Rest of Latin America Biobanking Market Revenue (US$ Mn) and Forecasts, By Function

18.8.3.2.1. Sample Collection

18.8.3.2.2. Sample Preparation

18.8.3.2.3. Sample Analysis and Data Management

18.8.3.2.4. Sample Storage

18.8.3.2.5. Sample Transportation

18.8.3.2.6. Others

18.8.3.3. Rest of Latin America Biobanking Market Revenue (US$ Mn) and Forecasts, By Application

18.8.3.3.1. Drug Discovery

18.8.3.3.2. Clinical Research

18.8.3.3.3. Life Science Research

18.8.3.3.4. Others

18.8.3.4. Rest of Latin America Biobanking Market Revenue (US$ Mn) and Forecasts, By Biological Sample Type

18.8.3.4.1. Blood Products

18.8.3.4.2. Human Waste

18.8.3.4.3. Cell Lines

18.8.3.4.4. Human Tissue

18.8.3.4.5. Others

18.8.3.5. Rest of Latin America Biobanking Market Revenue (US$ Mn) and Forecasts, By End Users

18.8.3.5.1. Biobanks

18.8.3.5.2. Pharma and Biotech Companies

18.8.3.5.3. Contract Research Organizations

18.8.3.5.4. Academic and Research Institutions

18.8.3.5.5. Others

18.8.3.6. Rest of Latin America Biobanking Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

18.8.3.6.1. Online

18.8.3.6.2. Offline

18.9. Key Segment for Channeling Investments

18.9.1. By Country

18.9.2. By Offering

18.9.3. By Function

18.9.4. By Application

18.9.5. By Biological Sample Type

18.9.6. By End Users

18.9.7. By Distribution Channel

19. Competitive Benchmarking

19.1. Market Share Analysis, 2020

19.2. Global Presence and Growth Strategies

19.2.1. Mergers and Acquisitions

19.2.2. Product Launches

19.2.3. Investments Trends

19.2.4. R&D Initiatives

20. Player Profiles

20.1. Agilent Technologies, Inc.,

20.1.1. Company Details

20.1.2. Company Overview

20.1.3. Product Offerings

20.1.4. Key Developments

20.1.5. Financial Analysis

20.1.6. SWOT Analysis

20.1.7. Business Strategies

20.2. Becton, Dickinson and Company

20.2.1. Company Details

20.2.2. Company Overview

20.2.3. Product Offerings

20.2.4. Key Developments

20.2.5. Financial Analysis

20.2.6. SWOT Analysis

20.2.7. Business Strategies

20.3. Brooks Life Sciences

20.3.1. Company Details

20.3.2. Company Overview

20.3.3. Product Offerings

20.3.4. Key Developments

20.3.5. Financial Analysis

20.3.6. SWOT Analysis

20.3.7. Business Strategies

20.4. CloudLIMS.com

20.4.1. Company Details

20.4.2. Company Overview

20.4.3. Product Offerings

20.4.4. Key Developments

20.4.5. Financial Analysis

20.4.6. SWOT Analysis

20.4.7. Business Strategies

20.5. Cryo Bio System

20.5.1. Company Details

20.5.2. Company Overview

20.5.3. Product Offerings

20.5.4. Key Developments

20.5.5. Financial Analysis

20.5.6. SWOT Analysis

20.5.7. Business Strategies

20.6. Hamilton Company

20.6.1. Company Details

20.6.2. Company Overview

20.6.3. Product Offerings

20.6.4. Key Developments

20.6.5. Financial Analysis

20.6.6. SWOT Analysis

20.6.7. Business Strategies

20.7. LabVantage Solutions Inc.

20.7.1. Company Details

20.7.2. Company Overview

20.7.3. Product Offerings

20.7.4. Key Developments

20.7.5. Financial Analysis

20.7.6. SWOT Analysis

20.7.7. Business Strategies

20.8. LabWare

20.8.1. Company Details

20.8.2. Company Overview

20.8.3. Product Offerings

20.8.4. Key Developments

20.8.5. Financial Analysis

20.8.6. SWOT Analysis

20.8.7. Business Strategies

20.9. LiCONiC AG

20.9.1. Company Details

20.9.2. Company Overview

20.9.3. Product Offerings

20.9.4. Key Developments

20.9.5. Financial Analysis

20.9.6. SWOT Analysis

20.9.7. Business Strategies

20.10. PHC Corporation

20.10.1. Company Details

20.10.2. Company Overview

20.10.3. Product Offerings

20.10.4. Key Developments

20.10.5. Financial Analysis

20.10.6. SWOT Analysis

20.10.7. Business Strategies

20.11. QIAGEN

20.11.1. Company Details

20.11.2. Company Overview

20.11.3. Product Offerings

20.11.4. Key Developments

20.11.5. Financial Analysis

20.11.6. SWOT Analysis

20.11.7. Business Strategies

20.12. Thermo Fisher Scientific Inc.

20.12.1. Company Details

20.12.2. Company Overview

20.12.3. Product Offerings

20.12.4. Key Developments

20.12.5. Financial Analysis

20.12.6. SWOT Analysis

20.12.7. Business Strategies

20.13. Other Market Participants

21. Key Findings

At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.

Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.

Prominent participants in our primary research process include:

Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
Research and development participants, distributors/suppliers and subject matter experts

Secondary Research includes data extracted from paid data sources:

Reuters
Factiva
Bloomberg
One Source
Hoovers

Research Methodology

Key Inclusions

Request A Sample

Ask for Discount

Enquiry Before Buying

Request For Customization

Purchase Options

Single users $4600

Multi users $8200

Global users $9100

Buy Now

Reach to us

Call us on

+91-74002-42424

Drop us an email at

sales@absolutemarketsinsights.com